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*Corresponding author Julia.bailey@ucl.ac.uk
Background: This report details the development of the Men’s Safer Sex website and the results of a
feasibility randomised controlled trial (RCT), health economic assessment and qualitative evaluation.
Objectives: (1) Develop the Men’s Safer Sex website to address barriers to condom use; (2) determine the
best design for an online RCT; (3) inform the methods for collecting and analysing health economic data;
(4) assess the Sexual Quality of Life (SQoL) questionnaire and European Quality of Life-5 Dimensions, three-
level version (EQ-5D-3L) to calculate quality-adjusted life-years (QALYs); and (5) explore clinic staff and men’s
views of online research methodology.
Methods: (1) Website development: we combined evidence from research literature and the views of
experts (n = 18) and male clinic users (n = 43); (2) feasibility RCT: 159 heterosexually active men were
recruited from three sexual health clinics and were randomised by computer to the Men’s Safer Sex
website plus usual care (n = 84) or usual clinic care only (n = 75). Men were invited to complete online
questionnaires at 3, 6, 9 and 12 months, and sexually transmitted infection (STI) diagnoses were recorded
from clinic notes at 12 months; (3) health economic evaluation: we investigated the impact of using
different questionnaires to calculate utilities and QALYs (the EQ-5D-3L and SQoL questionnaire), and
compared different methods to collect resource use; and (4) qualitative evaluation: thematic analysis of
interviews with 11 male trial participants and nine clinic staff, as well as free-text comments from online
outcome questionnaires.
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Results: (1) Software errors and clinic Wi-Fi access presented significant challenges. Response rates for
online questionnaires were poor but improved with larger vouchers (from 36% with £10 to 50% with
£30). Clinical records were located for 94% of participants for STI diagnoses. There were no group
differences in condomless sex with female partners [incidence rate ratio (IRR) 1.01, 95% confidence
interval (CI) 0.52 to 1.96]. New STI diagnoses were recorded for 8.8% (7/80) of the intervention group and
13.0% (9/69) of the control group (IRR 0.75, 95% CI 0.29 to 1.89). (2) Health-care resource data were
more complete using patient files than questionnaires. The probability that the intervention is cost-effective
is sensitive to the source of data used and whether or not data on intended pregnancies are included.
(3) The pilot RCT fitted well around clinical activities but 37% of the intervention group did not see the
Men’s Safer Sex website and technical problems were frustrating. Men’s views of the Men’s Safer Sex
website and research procedures were largely positive.
Conclusions: It would be feasible to conduct a large-scale RCT using clinic STI diagnoses as a primary
outcome; however, technical errors and a poor response rate limited the collection of online self-reported
outcomes. The next steps are (1) to optimise software for online trials, (2) to find the best ways to
integrate digital health promotion with clinical services, (3) to develop more precise methods for collecting
resource use data and (4) to work out how to overcome barriers to digital intervention testing and
implementation in the NHS.
Trial registration: Current Controlled Trials ISRCTN18649610.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 20, No. 91. See the NIHR Journals Library website
for further project information.
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Plain English summary
The Men’s Safer Sex website gives advice about sexual health and how to avoid sexually transmittedinfections (STIs). We wanted to find out whether or not the website is useful for men in sexual health
clinics and how best to run research. Men signed up for the study on an iPad® (Apple Inc., Cupertino, CA,
USA) in clinic waiting rooms and allocated to:
1. The ‘no website’ group: asked to complete online surveys via e-mail 3, 6 and 12 months later.
2. The ‘website’ group: asked to look at the Men’s Safer Sex website while they were waiting and to then
fill in online surveys 3, 6, 9 and 12 months later.
We checked men’s clinic records after 1 year and also interviewed 11 men and nine members of staff.
We found that:
l men were happy to do online research
l staff and patients felt that a sexual health website is a good idea
l staff asked men to join the study, rather men registering on iPads on their own
l there were a lot of technical problems
l one-third of the experimental group did not actually see the Men’s Safer Sex website
l privacy and confidentiality is very important
l only half of the men filled in the online surveys
l we collected useful information on STIs and costs from medical records
l there were fewer infections in the group who received the Men’s Safer Sex website (9% vs. 13%), but
this difference might have happened by chance
l the website did not seem to cause any harm and men thought it could be helpful.
The next steps are to work out how to solve practical and technical problems before health promotion
websites can be tested and used in NHS settings.
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Sexually transmitted infections (STIs) are a major public health problem with high social and economic
costs. Condoms are effective for the prevention of STI acquisition but there are many barriers to the
successful use of condoms.
Men are less likely than women to visit health professionals and can be reluctant to discuss their sexual
health with practitioners, partners or friends. An online intervention offers an alternative way to reach men
at risk of acquiring STIs. Digital interventions are very suitable for sexual health promotion because access
can be private, anonymous and self-paced. Interventions can be targeted for specific groups (e.g. by age,
sex or sexuality) and content can be tailored for individuals. Interactive digital interventions (IDIs) can be
expensive to develop but offer the advantages of intervention content fidelity and the potential to reach
large audiences at relatively low dissemination costs. IDIs can improve sexual behaviour as well as
increasing knowledge, self-efficacy and safer sex intention, but there are few interventions for men who
have sex with women and more evidence is needed to establish the effects on biological outcomes, such
as STIs, as well as cost-effectiveness.
The Men’s Safer Sex website is an IDI which provides information and tailored advice on sexual well-being
and barriers to condom use. The website was offered to heterosexual men in the waiting rooms of NHS sexual
health clinics, with the aim of increasing condom use and reducing the acquisition of STIs. This report details the
development, design and content of the Men’s Safer Sex website, and the results of feasibility evaluations
[a pilot randomised controlled trial (RCT), a health economic assessment and a qualitative evaluation].
Aim and objectives
Aim
To assess the feasibility and best design of a large-scale RCT and health economic evaluation of the Men’s
Safer Sex website.
Objectives
1. To develop an interactive, tailored, website that addresses men’s barriers to condom use.
2. To determine the feasibility and best design for a RCT to test the effect of the Men’s Safer Sex website
on condom use and acquisition of STIs among men attending sexual health clinics.
3. To inform the methods for collecting and analysing cost and outcome data for a cost-effectiveness
analysis alongside a Phase III trial.
4. To assess the suitability of using the Sexual Quality of Life (SQoL) questionnaire, European Quality
of Life-5 Dimensions, three-level version (EQ-5D-3L) and associated utility scores to calculate
quality-adjusted life-years (QALYs) for an incremental cost–utility ratio.
5. To explore the views of clinic staff and male clinic attendees regarding the online research methodology.
Methods
Intervention development method
We used the Behaviour Change Wheel to combine evidence from research literature with the views of
sexual health and eHealth experts as well as those of male clinic users to develop a website that provided
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individually tailored advice on barriers to condom use, especially on the impact of condoms on sexual
pleasure. We incorporated behaviour change techniques throughout the website.
Feasibility randomised controlled trial method
A total of 159 men aged ≥ 16 years with female sexual partners and recent condomless sex or a suspected
acute STI were recruited from three English sexual health clinics. Trial procedures were online, with online
eligibility, consent, registration, randomisation and data collection. Participants were randomised to receive
the Men’s Safer Sex website plus usual clinic care (n = 84) or usual clinic care only (n = 75). Men were
invited via e-mail to complete online questionnaires at 3, 6, 9 and 12 months. STI diagnoses were recorded
from clinic notes at 12 months and the primary outcome was retention in the trial at 3 months. Online
shopping vouchers worth up to £50 were offered for completing the online questionnaires.
Health economic evaluation methods
The aim of the health economic evaluation was to assess the feasibility of an economic evaluation as part
of a Phase III trial and to inform the methods for future data collection. Sexual health-related resource use
was collected from two sources: participants’ sexual health clinical records and participant responses to
questionnaires at 3, 6, 9 and 12 months. Utility scores to calculate QALYs were collected using two
different questionnaires: (1) generic preference-based measure of health-related quality of life (HRQoL) –
the EQ-5D-3L and (2) a sexual health-specific HRQoL measure – the SQoL questionnaire. The incremental
cost per QALY was calculated to investigate the impact of using different questionnaires to calculate
utilities and QALYs and using different methods to collect resource use.
Qualitative evaluation method
Semistructured interviews were conducted with 11 men who had participated in the pilot RCT and with
nine clinic staff. We also collated free-text comments taken from the online outcome questionnaires.
Interviews were audio-recorded and transcribed, and a thematic analysis of these three data sources was
conducted to identify themes.
Results
Feasibility randomised controlled trial results
Recruitment via a tablet computer in the waiting rooms of sexual health clinics was successful. Retention
within the trial was a significant problem owing to software technical problems and low response rates to
the online questionnaire (36% at 3 and 6 months, and 50% at 12 months). Clinical records were located
for 94% of participants (for STI diagnoses > 12 months). There was no detectable difference between the
intervention and control in condomless sex with female partners between groups, but the numbers were
very small owing to the low survey response rate [incidence rate ratio (IRR) 1.01, 95% confidence interval
(CI) 0.52 to 1.96]. There were fewer clinical diagnoses of STIs over 1 year in the intervention group who
were offered the Men’s Safer Sex website but the differences were non-significant (IRR 0.75, 95% CI 0.29
to 1.89). No harmful effects or adverse events were identified.
Health economic assessment results
The probability that the Men’s Safer Sex website was cost-effective compared with current practice
differed by whether data from questionnaires or clinical records were used. Resource use for sexual health
clinics taken from questionnaire responses accounted for 84–87% of costs, capturing the majority of cost
data. There was a significant decrease in QALYs calculated using the EQ-5D-3L for patients with a STI at
baseline but no change detected by the SQoL questionnaire.
Qualitative evaluation results
Male clinic users felt that the Men’s Safer Sex website could be useful, especially for men who do not
want to discuss their sex lives, but both staff and clinic users did not want a website to replace face-to-face
health care. The pilot RCT fitted well around clinical activities, but men did not self-direct to the iPads®
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(Apple Inc., Cupertino, CA, USA) and technical problems hampered website access and data collection.
Staff were more concerned about consent and confidentiality than clinic users. Experiences of the sexual
health questionnaire and follow-up procedures were widely positive. The outcome questionnaire was
sometimes thought-provoking and could constitute an intervention in itself.
Conclusions
The Men’s Safer Sex website was broadly well-received by male patients and clinic staff, and we were able
to measure the impact of the website on the acquisition of STIs by checking clinical notes. It is likely to be
feasible to conduct a future large-scale RCT to assess the impact of an online intervention using clinic STI
diagnoses as a primary outcome; however, technical errors and low response rates limited the collection
of online self-reported outcomes. There were challenges with unreliable research software and lengthy
research procedures, which hampered online self-reported data collection and access to the Men’s Safer
Sex intervention. Response rates were boosted following a higher-value incentive, but remained poor
(50%) at 6 months. There were no reported harmful effects from the Men’s Safer Sex website and it has
the potential to be cost-effective. Qualitative evaluation indicates that the Men’s Safer Sex website can
prompt useful changes in attitudes and behaviour for some men. We need to know more about how
the digital intervention might work, for whom and when, and how to ensure that participants engage
with a digital intervention for long enough to effect change. Practical and technical challenges need to be
addressed before a large-scale RCT is warranted.
The next steps
1. To refine the Men’s Safer Sex website in the light of suggestions made by men and by clinic staff.
2. To draw on our experiences and the latest software security protocols to develop a reliable and secure
software framework for online trials.
3. To optimise online research procedures (e.g. information formats suitable for reading online, efficient
registration procedures and minimal baseline outcome measurement).
4. To conduct qualitative work with patients, clinic staff and other stakeholders to investigate the best
ways to incorporate digital health promotion into NHS clinic pathways, to benefit both patients and
clinic staff.
5. To explore potential mechanisms of action of the Men’s Safer Sex digital interventions, including the
best ways to enhance engagement with the website.
6. To develop more precise estimations of the costs of service use and resources through capturing better
data on clinic staff costs, time and resources allocated to each patient.
Public health policy advocates the use of digital interventions for health and these interventions have the
potential to offer cost-effective sexual health promotion. However, we encountered significant obstacles
to online research and to engagement with the Men’s Safer Sex website in NHS clinic settings. Interactive
digital interventions show exciting potential for health promotion but, first, we need to overcome barriers
to digital intervention testing and implementation in NHS clinical settings.
Trial registration
This trial is registered as ISRCTN18649610.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Sexually transmitted infections (STIs) are a major public health problem as they result in high social and
economic costs.1,2 Condoms are effective for prevention of STIs, but there are many barriers to successful
condom use, for example decrease in sensation, interruption of sex, incorrect size or fit, use of alcohol/
recreational drugs, anxiety affecting sexual performance and stigma associated with carrying condoms.3,4
Condoms may be perceived as a barrier to intimacy and trust,4 and their use is often lower in
established relationships.5
As men often have the power to influence condom use for penetrative sex (because they wear condoms),
efforts are needed to target the obstacles to condom use that men face.3 Although there are a variety of
health promotion interventions aimed at improving sexual health for men who have sex with men (MSM),
there are fewer interventions specifically for adult men who have sex with women (MSW),6,7 despite the
fact that MSW report much less consistent condom use than MSM.8 Men are less likely than women to
visit health professionals and generally have shorter clinic appointments,9,10 and so may be less likely to be
offered health promotional advice or risk reduction counselling in the context of routine appointments.
Furthermore, men may be reluctant to discuss their sexual health with health professionals, partners or
friends.11 Therefore, an online intervention offers an alternative avenue to reach out to men.12
Sexual health interventions
Guidance from the National Institute for Health and Care Excellence (NICE)1 recommends that people at a high
risk of acquiring STIs are offered one-to-one structured discussions to address risk-taking and this is increasingly
being offered as part of routine care in genitourinary medicine and other health-care settings. Although
interventions such as motivational interviewing can have an impact on sexual behaviour,1 in practice, it is
resource intensive to train and support staff and difficult to find time for structured discussions in busy clinical
services. A potential alternative to such interventions is the use of interactive digital interventions (IDIs).
We define IDIs as ‘computer-based programmes that provide information and one or more of decision
support, behaviour-change support, or emotional support for health issues’.12 IDIs require contributions
from users to produce personally relevant tailored material and feedback, and are highly suitable for sexual
health promotion because access can be private, anonymous and self-paced,13 which may be particularly
important for men who may be reluctant to disclose a lack of knowledge or skill. Interventions can be
targeted for specific groups (e.g. by age, sex or sexuality) and content can be tailored for individuals.14
IDIs can be expensive to develop, but offer the advantages of intervention fidelity15 and the potential to
reach large audiences at relatively low dissemination costs.
Interactive digital interventions can improve sexual behaviour (including condom use) as well as increasing
knowledge, self-efficacy and safer sex intention.12,16 Further evidence is needed to establish the effects
on biological outcomes, such as STIs, and cost-effectiveness. Interventions are more likely to be effective
if they are grounded in theory17 and involve a high level of user input in the development process.18
Therefore, this project sought to develop a theory- and evidence-based IDI, developed with a high level of
user input, which was aimed at increasing condom use in MSW. This report outlines the development
process of the IDI, a pilot trial of the IDI, a health economic assessment and a qualitative evaluation of the
trial procedures. The overall aim was to produce a rigorously developed intervention underpinned by
behaviour change theory, and recommendations for how this intervention could be assessed for clinical
effectiveness and cost-effectiveness in sexual health clinic settings.
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Chapter 2 Intervention development
Introduction
Understanding the exact nature and content of complex behaviour change interventions is important
for understanding which intervention components are the ‘active ingredients’ of a behaviour change
intervention;19 however, intervention designs are not often well described in publications.20 As a result,
replication is difficult and future intervention designers cannot learn from what is and what is not
effective.20,21 Lack of detail in the description of the content and development process for an intervention
limits the evaluation of its quality or the possibility of linking content to outcome. A further issue is that,
even if one is aware that theory and user involvement should be incorporated into intervention
development, it can be difficult to know exactly how to achieve this.
This paper outlines the development process of the Men’s Safer Sex website and, thus, provides
transparency for readers and an example of how an evidence- and theory-based IDI may be developed.
The Behaviour Change Wheel
The Behaviour Change Wheel (BCW) (Figure 1) is one method that can be used to guide this process.23
It provides a framework for the process of developing complex interventions and it represents a synthesis
of 19 theoretical frameworks of behaviour change pathways. It has the advantage of being comprehensive
(i.e. it covers all the main intervention functions and policy categories), coherent (i.e. categories within it
are consistent and it provides systematic steps for intervention design) and linked to an overarching model
of behaviour. The BCW has been used to develop interventions that were both acceptable to users and




























































































































FIGURE 1 The BCW.22,23 © Michie et al.; licensee BioMed Central Ltd. 2011. This article is published under licence
to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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The main steps are as follows.
Step 1: specifying the target behaviour and population
This involves specifying who needs to do what, where, when and how often. Having a specific target
behaviour allows for a focused development process and facilitates deciding on appropriate measurable
outcomes.22 A well-defined target population enables the intervention developer to select an appropriate
platform and tailor the content to the user’s specific needs and preferences.
Step 2: identifying theoretical domains that explain the behaviour
At the heart of the BCW is a model in which behaviour change is conceptualised as requiring a shift in
capability, opportunity and/or motivation, with these three drivers being part of an interacting system
[the capability, opportunity, motivation, behaviour (COM-B) model, see Figure 1]. Capability may be physical
or psychological, opportunity may be physical or social and motivation may be reflective or automatic. These
subdivisions can be further elaborated into 14 detailed theoretical domains, specified by the theoretical
domains framework (TDF) (Table 1).27 The TDF is an amalgamation of 128 theoretical constructs from
33 theories of behaviour and behaviour change. It can be used to conduct a theoretically based assessment
of the problem,28,29 which identifies mechanisms of action to be targeted by the intervention. The advantage
of using the TDF over a single theory of health behaviour is that it delineates multiple distinct explanatory
domains, which may be more appropriate for the development of a complex intervention, as a greater
number of potential influences on behaviour can be considered.
Step 3: identifying how explanatory domains should be targeted
The BCW outlines nine possible ‘intervention functions’ that may be utilised: education, persuasion,
incentivisation, coercion, training, restrictions, environmental restructuring, modelling and enablement.
These delineate what ‘function’ the intervention will serve (i.e. to educate people, to train people, to
coerce people) and appropriate functions are recommended for each of the explanatory domains identified
in Step 2: identifying theoretical domains that explain the behaviour.22,23 At this point, it is important to
consider which methods will be most appropriate for the intervention given its context, that is target
population and setting (e.g. in terms of acceptability, affordability and practicability).22
TABLE 1 Explanatory domains for behaviour change
COM-B component TDF domain
Capability Psychological Knowledge
Cognitive and interpersonal skills
Memory, attention and decision processes
Behavioural regulation
Physical Skills
Opportunity Social Social influences
Physical Environmental context and resources
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Step 4: selecting standardised behaviour change techniques
Once intervention functions have been identified, it is possible to identify the standardised behaviour
change techniques (BCTs) that are relevant to each function. A BCT is an active component of an
intervention designed to change behaviour30 and BCTs are applicable to a range of health behaviours.31
One can therefore select BCTs considering the appropriateness for the population, setting and intervention
format. This approach has been used successfully in a range of interventions varying in mode of delivery,
content, target behaviour and context.21,24,32
In addition to the steps outlined here, the BCW also includes nine ‘policy’ categories to select from when
developing interventions on a wider scale, for example changing legislation to encourage behaviour change
on a population level; however, these were not considered relevant for this (individual-level) intervention.
The development process33 and content34 of the intervention are also reported elsewhere.
Methods
Three sources of data were used to inform the intervention development process: research literature,
expert consultation and interviews with the target population (men in sexual health clinics). The BCW and
the TDF were used as frameworks to guide the analysis and synthesis of the evidence. Ethics approval was
provided by the London City and East NHS Research Ethics Committee (reference number 13/LO/1801).




A targeted literature review identified research on men’s barriers to condom use. Search terms included
‘men’, ‘heterosexual’, ‘condom’ and ‘barriers’. Databases searched included Web of Knowledge databases
(including MEDLINE, EMBASE, PsycINFO) and Google Scholar (Google Inc., Mountain View, CA, USA),
selecting articles on risk factors for non-condom use, theoretical correlates of condom use and men’s
barriers to using condoms. The full text of 27 papers was included, consisting of reviews, qualitative
studies and cross-sectional, longitudinal, population-based and experimental designs.33 These were
summarised and synthesised into themes and subthemes (Table 2).
Expert consultation
Two expert workshops were held. Attendees at the first day-long workshop included 13 experts in the
area of men’s sexual health and/or behaviour change, including sexual health clinicians, health advisors
and academic professors. The workshop was structured around the BCW, asking participants to give their
opinions about the explanatory domains, intervention functions and the format of the intervention.
A second (half-day) workshop was held following interviews with male clinic attenders to guide final
decisions regarding the intervention design and content. This workshop included five experts in the fields
of sexual health, sex education and web development. Participants were presented with the findings from
the development process and asked to prioritise aspects of intervention content. This informed decisions
regarding resource allocation during the creative process of designing intervention features. For example,
while interactive features were considered the ideal, budget constraints meant that we could not develop
interactive features to target every influence on behaviour. Therefore, some ‘lower priority’ influences on
behaviour (or those for which interactive features were deemed inappropriate, e.g. sexual pleasure) were
targeted with written information.
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Interviews with the target population
Semistructured qualitative interviews were conducted with 20 men who visited sexual health clinics to gain
information from the target population regarding barriers to, and facilitators of, condom use, as well as
potential intervention design, content and mode of delivery.
Participants were recruited from two sexual health clinics in central London. Men attending sexual health
drop-in clinics between February and April 2013, who were aged > 18 years and who had not been
diagnosed with human immunodeficiency virus (HIV) or hepatitis were eligible to participate. They were
given a leaflet about the study and asked to approach the researcher if they wished to take part.
Participants were aged between 20 and 52 years (mean = 31 years); seven identified themselves as white
British, nine as black (black African or British), two as European, one as Chinese and one as mixed
ethnicity; 17 interviewees were currently sexually active with female partners and three with male partners
(the decision to focus solely on MSW was made partway through the fieldwork process, hence why a small
number of MSM were included in the sample).
TABLE 2 Barriers to and facilitators of condom use
Theme Subtheme
Barriers to condom use Pleasure
Interruption of sexual activity
Intimacy
Making judgements about risk




Lack of perceived risk
Condom problems (e.g. breaking, discomfort)
Lack of awareness about risk of oral sex
Facilitators of condom use Condoms as prevention against pregnancy
Reflection on past behaviour as a motivator
Awareness/close personal experience of pregnancy or STI
Seeing condom use as an ‘essential behaviour’
Avoidance of STI
Dislike of visiting clinic
Having condoms available





Perceived benefits and barriers
Outcome expectancies
INTERVENTION DEVELOPMENT
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Participants were asked about their experiences and views on using condoms and their interest in a
potential sexual health website. Interviews lasted between 30 and 60 minutes and were audio-recorded.
The recordings were listened to, and initial themes summarised and then analysed using qualitative
thematic content analysis35 and the categories provided by the BCW.22,23
User testing
Focus groups (n = 3) were held with male sexual health clinic users (N = 16) to refine the Men’s Safer Sex
website content and design. After each focus group, themes were summarised and content and design
changes were made in response to the feedback. Once an initial version of the website was ready,
interviews were conducted with male sexual health clinic users (n = 7) to ensure acceptability, relevance
and understanding, and to identify any software errors or usability issues. These findings fed into the final
version of the intervention.
Intervention development: processes and outcomes
The following section outlines the methods (processes) and results (outcomes, i.e. implications for the
intervention) for each step of the intervention development process.
Step 1: specifying the target behaviour and population
Process
The target behaviour and population were discussed at the initial expert workshop. Final decisions
regarding this were made by the study team.
Outcome
Condom use was predefined as the specified target behaviour. MSM were identified in the expert
workshop as a high-risk group for acquiring STIs; however, the research team identified a number of
existing interventions for MSM but a lack of interventions for MSW;6,7 therefore, it was decided that the
intervention would target MSW. Men in sexual health clinic settings may be at higher risk of repeat STIs,36
as having had one STI is a risk factor for acquiring another, and so it was decided that the intervention
would be targeted at men in clinic settings. We worded the website advice in a gender-neutral way,
whenever possible, to make it relevant for men with any sex of partner(s) (e.g. how to tackle problems with
condoms). However, the Men’s Safer Sex website particularly targeted MSW, as they are underserved with
web resources, and photographic images represented women as sexual partners and not men.
The target behaviour and population also influenced the choice of intervention format (i.e. an interactive
website or a smartphone application). Technology-use data suggested that there was a high level of
smartphone use in the target population; however, it was difficult to select a platform [e.g. Android™
(Google Inc., Mountain View, CA, USA), iOS (Apple Inc. Cupertino, CA, USA)] that was used by the majority
of the population and the budget precluded developing the application for more than one platform. Issues
of privacy or lack of motivation were also a concern for potentially preventing users from downloading
an application about condoms onto their smartphone. As a result, it was decided that the intervention would
take the form of an interactive website, rather than a smartphone application.
Step 2: identifying theoretical domains that explain the behaviour
Process
In order to determine which domains should be targeted within the intervention, data from the interviews,
workshops and literature review were organised into the categories of the COM-B and TDF (see Table 1),
coding the data using the TDF as a coding frame, initially for each data source, then findings were
synthesised. Domains were prioritised in order of importance to guide decisions regarding what to target
with the website, considering available resources. Domains were considered important if they were
strongly supported by all three data sources. When evidence from the data sources was conflicting,
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the research team discussed each case and made a decision regarding whether or not it should be
targeted and how much of a priority it should be, drawing on their knowledge and experience of the field.
Outcome
Out of the 14 domains in the TDF, 12 were deemed to be important and were therefore targeted by the
intervention: skills; knowledge; cognitive and interpersonal skills; social/professional role and identity;
beliefs about capabilities; beliefs about consequences; goals; intentions; memory, attention and decision
processes; emotion; environmental context and resources; and social influences (Table 3).
The most prominent domains were beliefs about consequences (impact on pleasure), knowledge (about
risk of STIs and about condom sizes and types) and memory, attention and decision processes/emotion
(difficulty using condoms in the ‘heat of the moment’). Therefore, psychological capability and reflective
and automatic motivation were found to be important targets for change for this population.
Some domains contained one or more subthemes. ‘Beliefs about consequences’ incorporated both beliefs
about the impact of condoms on sexual pleasure and the belief that STIs were not serious and did not
have negative long-term consequences for men. A prominent aspect of knowledge was knowledge about
the risk of acquiring STIs; men often felt that they could judge the risk of a situation (e.g. by a partner’s
appearance or whether or not the partner was in a relationship). In addition, a lack of knowledge
regarding condom sizes and types and how they might impact on sexual pleasure was identified. Some
barriers to condom use fell into more than one domain, for example being caught in the ‘heat of the
moment’ was considered to come under ‘emotion’ as it relates to lust; however, this emotion also
interfered with memory, attention and decision processes.
For some domains, the sources of evidence were inconsistent. For example, both experts and interview
participants considered that men possessed the skills in applying condoms; however, evidence from the
literature suggests that rates of errors in condom use are high (e.g. putting it on the wrong way then
turning it over, failing to squeeze air from the tip).37 Therefore, the research team decided that it was
important to target this domain.
Step 3: identifying how explanatory domains should be targeted
Process
Once appropriate domains had been selected, intervention functions were then identified by reviewing the
possibilities for each domain as defined in the BCW guide22 and considering which functions were likely to
be most effective given the fieldwork findings. Consideration was given to the preferences outlined by
participants in the interviews as well as what would be feasible and affordable to include (in terms of
software development).
TABLE 3 Behaviour change mechanisms targeting barriers to condom use
Domain Findings Intervention functions BCTs
Skills High rate of errors in condom
use37
Training Instruction on how to perform the
behaviour; demonstration of the
behaviour
Knowledge Men lacked knowledge about
condom sizes and types and
how they may improve pleasure
and comfort (interviews)
Enablement Problem-solving
Men had incorrect knowledge
about risk of acquiring STIs
(interviews); knowledge about
risk is related to condom use38
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TABLE 3 Behaviour change mechanisms targeting barriers to condom use (continued )
Domain Findings Intervention functions BCTs
Cognitive and
interpersonal skills
Communication related to use of
condoms;38 difficulty knowing
when to suggest condom use
(interviews); fear that partner
may be offended;39 difficulty




Instruction on how to perform the
behaviour; information about social
and environmental consequences;







Being caught in the ‘heat of the
moment’ leads to non-condom
use (owing to high level of
arousal and lust and competing






about capability; information about
health consequences; instruction









Self-concept and values are
related to condom use39,41
(e.g. fostering/reinforcing being
‘responsible person’, who cares
about others’ health, may be a
facilitator of condom use)
Persuasion Information about others’ approval
Beliefs about
capabilities
Literature suggested this may
be an important predictor of
behaviour38,42
Enablement Verbal persuasion about capability;





negatively impact on pleasure








instructions on how to perform the
behaviour; behaviour substitution;
information about health
consequences; focus on past
success, distraction; behavioural
practice/rehearsal; anticipated
regret; information about social
and environmental consequences;
social incentive
Belief that STIs do not have
negative consequences for men
(interviews)
Education Information about health
consequences
Intentions Literature suggested this may
be an important predictor of
behaviour38,49
The aim of the intervention as a whole was to increase
intention. Specific intervention functions and BCTs not identified
Goals Goal-setting may be an
important tool to implement






Intoxication owing to alcohol or










Social influence Men generally had a desire for
a good reputation for sexual
performance and their partner’s




Information about others’ approval;
social incentive
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Outcome
A full outline of the intervention functions selected for each domain can be found in Table 3. For the
majority of domains, the intervention functions were very straightforward to select. For example, ‘skills’
lends itself to ‘training’ and ‘knowledge’ lends itself to ‘education’. Persuasion and enablement were used
in a number of sections of the website to target motivation. Coercion and restriction were deemed to be
inappropriate, unfeasible and potentially unacceptable to participants.
Step 4: selecting standardised behaviour change techniques
Process
A number of potential BCTs appropriate for each intervention domain and function were identified using
the BCW guide.22,31 These were reviewed for appropriateness to the population and intervention format,
and a list of proposed BCTs for each domain was created. The selected BCTs were translated into the
website intervention features and activities in a creative process involving the research team and the
software development company, which also ensured that the ideas were feasible and affordable. Website
content was then reviewed in comparison with the BCT taxonomy31 to confirm that activities and wording
met the standardised criteria for each proposed BCT.
Outcome
Once BCTs were selected, they needed to be conceptualised into intervention features. The intervention
website was designed to be ‘interactive’, whereby users can input information and get personalised
feedback within the website. Resources were focused on domains which (1) were deemed most important
and (2) afforded themselves to interactive features. For example, an interactive feature which addressed
barriers to condom use (‘problem-solving’) solicited men’s own problems with condoms and then provided
tailored information regarding condom types to address those problems. Giving ‘information about health
consequences’ was made more engaging by asking users to guess the answers to questions about STI risk.
Intervention content
Here we describe the content and functionality of the intervention website by providing each intervention
section/topic, the rationale for it, the relevant BCTs and the subsequent content included in the intervention.
Barriers to condom use
Rationale
Interventions that are tailored to users are more likely to be effective.53 The interviews and literature review




On first using the website, users were asked to select the reasons why they personally did not use condoms
from 12 possible options, which were identified through our fieldwork (condoms too tight or uncomfortable,
reduced pleasure, not knowing when or how to suggest it, being drunk or having taken drugs, losing
erection, being in a relationship, difficulty stopping in the heat of the moment, partner not wanting to use
condoms, partner might be offended, sex does not feel as good, STIs are easily treated and they often break
or slip off). The homepage (Figure 2) was then tailored to each individual user by ensuring that the content
that addressed the barriers selected was displayed prominently in the centre of the page.
INTERVENTION DEVELOPMENT
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Although data from the workshops and interviews suggested that men feel competent in applying
condoms, the literature review identified high rates of errors and problems with condom use.37,54
Behaviour change techniques
l Instructions for how to perform the behaviour.
l Demonstration of the behaviour.
Content
This section included a short video demonstration and a click-through slideshow, which provided advice
about using condoms correctly, highlighting the key steps in condom use and the areas in which people
often make mistakes (Figure 3).
Condoms: tailored for you
Rationale
Evidence from our qualitative work and the literature suggested that condom size and type had a strong
impact on acceptability of condoms, with poorly fitting or thicker condoms being viewed more negatively.




The intervention website aimed to educate men about different sizes and types of condom, using a tailored
feedback activity. In this activity, users were asked to identify problems they had with condoms and then
offered tailored advice about and recommendations for condom types to help address those problems
(Figure 4). For example, men suggesting that condoms were uncomfortable, small or problematic for
breaking were offered advice about larger types of condoms. This activity was similar to the ‘barriers to
condom use’ activity but focused on problems with the actual condom (rather than problems surrounding
condom use in general), and gives specific condom-related feedback and recommendations.
Pleasure
Rationale
All data sources indicated that the belief that condoms reduce the pleasure of sex is a very important and
common barrier to condom use.
Behaviour change techniques
l Non-specific incentive.
l Restructuring the physical environment.
l Instructions on how to perform the behaviour.
l Behaviour substitution.
l Information about health consequences.
l Focus on past success, distraction.
l Behavioural practice/rehearsal.
l Anticipated regret.
l Information about social and environmental consequences.
l Social incentive.
INTERVENTION DEVELOPMENT
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Content
This section incorporated written advice and videos. It gave advice about how to improve pleasure with
condoms, how sex with condoms might be preferable to sex without condoms [e.g. by reducing worry
(non-specific incentive)], how there are types of condom that may be more pleasurable and how to enjoy
non-penetrative sex (behavioural substitution). BCTs were conceptualised within written text; for example,
the ‘anticipated regret’ technique encouraged users to focus on avoiding the worry and hassle that may
follow an episode of condomless sex and the ‘focus on past success’ technique was incorporated by
encouraging men who had previously had problems with loss of erection to focus on occasions when they
had not lost their erection.
FIGURE 3 Condoms: the basics – skills in correct condom application.
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Sexually transmitted infections: are you at risk?
Rationale
All the data sources suggested that men were aware of the benefits of using condoms and of some of the
risks of condomless sex;38 however, our interviews highlighted a number of widespread incorrect beliefs
about the risk of STIs (e.g. partners who are known to them or ‘seem clean’ are viewed as less risky).
Behaviour change techniques
l Information about health consequences.
l Vicarious consequences.
Content
The intervention included two interactive activities addressing STI risk, emphasising that the likelihood of
acquiring STIs cannot be accurately judged (Figure 5). First, in ‘What’s the risk of STIs?’ a quiz presented
FIGURE 4 Tailored feedback on selected barriers to condom use.
INTERVENTION DEVELOPMENT
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facts and figures regarding STIs and their transmission (e.g. the number of people with undiagnosed HIV).
This conceptualised the BCT of ‘information about health consequences’ in an interactive and visually
appealing manner. Second, in ‘Are relationships safe?’ two animated diagrams demonstrated the way that
STIs may spread within a network, common methods of transmission that people may not be aware of
(e.g. oral sex) and how relationships may not be ‘safe’. This activity encompassed the BCT of ‘information
about health consequences’, and also used ‘vicarious consequences’, by demonstrating the impact of risky
sexual behaviours on others.
What women think
Rationale
Both the literature39 and our interviews with men identified fear of partners reacting negatively to suggestions
of condom use as an important barrier to condom use. The literature also suggests that self-concept and
personal values are related to carrying and using condoms;39,41 if a healthy behaviour is consistent with one’s
identity, one may be more likely to perform the behaviour.56 Our workshops and interviews identified
fostering a sense of responsibility towards others as a potentially important factor in condom use.
Behaviour change techniques
l Information about others’ approval.
l Social incentive.
FIGURE 5 Sexually transmitted infections: are you at risk? Infographics illustrating potential risks of STIs.
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Content
This section included articles and videos portraying women as approving of men taking the responsibility
for condom use and women not being offended by the suggestion of condoms. It also provided advice on
responding to women who appeared to be offended. BCTs were conceptualised in written text and in
videos, for example ‘social incentive’ was offered by suggesting that women would view men positively if
they suggested condom use.
Slip-ups
Rationale
Pleasure or lust (being caught ‘in the heat of the moment’) was a widely quoted reason for non-use of
condoms within the literature and our interviews with men.3,57 All data sources identified alcohol as a
strong barrier to condom use. The importance of carrying/the availability of condoms has been related to
condom use in the literature and lack of availability was identified as a barrier by experts in the workshops.
Behaviour change techniques
l Problem-solving.
l Verbal persuasion about capability.
l Information about health consequences.
l Instruction on how to perform a behaviour.
l Information about antecedents.
l Restructuring the physical environment.
l Anticipated regret.
l Mental rehearsal of successful performance.
l Information about social and environmental consequences.
l Non-specific incentive.
Content
This section included articles and videos giving specific advice about how to overcome barriers due to the
‘heat of the moment’ and intoxication by discussing condoms with a partner in advance (instruction on
how to perform the behaviour), considering potential regret (anticipated regret) and avoiding sex when
under the influence of alcohol (information about antecedents). It also provided advice regarding making
condoms available (e.g. carrying them, having them near the bed) (restructuring the physical environment).
Again, BCTs were conceptualised in written text (e.g. the ‘verbal persuasion about capability’ technique
included messages that men would be able to use condoms, despite high levels of arousal or intoxication).
The ‘non-specific incentive’ technique was incorporated by telling users that if they wait to have sex when
they are not intoxicated, they may perform better, please their partner more and get a better reputation
for being a good lover.
Sexually transmitted infections: the facts
Rationale
In the qualitative interviews, men showed a lack of concern for catching STIs, as they did not feel that STIs
had substantial negative consequences for men.
Behaviour change techniques
l Information about health consequences.
INTERVENTION DEVELOPMENT
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Content
Users were presented with common misconceptions or questions about STIs and their transmission




Although the literature38 and the experts in our workshop suggested that difficulties in negotiating
condom use was a more salient barrier for women, evidence from the interviews with men suggested that,
for some, this was an issue, and for most men the opinions of their partner were important when deciding
whether or not to use a condom.
Behaviour change techniques
l Instruction on how to perform the behaviour.
l Information about social and environmental consequences.
l Information about others’ approval.
l Information about health consequences.
l Verbal persuasion about capability.
Content
This section offered information about specific strategies for suggesting, discussing and negotiating
condom use. BCTs were conceptualised in written information, for example ‘information about social and
environmental consequences’ included giving advice that talking about condoms before sex would mean
both partners can relax and enjoy it, rather than worrying about STIs or pregnancy, and ‘information about




Based on evidence from the literature50,51 and our workshops, goal-setting was identified as an important




l Review behaviour goals.
Content
In each section of the website, users were offered goals to set which related to the website content
(Figure 6). When selected, these goals populated users’ own personalised ‘Reminders and plans’ page.
Users could opt to receive a reminder by e-mail at a specific time, set time-limited goals (e.g. ‘I will
purchase my recommended condoms’ by a selected date) or choose event-specific goals by forming an
implementation intention58 (‘if-then plan’), identifying a potential situation for which condom use may be
unlikely and then selecting a response to that situation.
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Increased engagement with an IDIs can lead to increased effectiveness.59 Encouraging users to engage in
IDIs, particularly over a long period of time, is notoriously difficult.60 E-mail prompts can be used to
increase engagement with the intervention.61
Behaviour change techniques
l Prompts and cues.
l Information about health consequences.
l Review behaviour goals.
FIGURE 6 ‘Reminders and plans’ feature.
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Content
Users were sent monthly e-mails prompting them to visit the intervention website. These contained
‘teasers’ regarding website information and links to the website (e.g. ‘Do you know how many people
have chlamydia? Find out here’). In addition, if users set goals or implementation intentions within the
website, they could select the option of being reminded via e-mail. These e-mails asked users if they had
achieved their goal and prompted them to return to the website to review their goals.
Discussion
Triangulation between a targeted literature review, expert workshops and interviews with the target
population, all led by a multidisciplinary team, ensured that a range of potential influences on condom use
were captured and that feedback to men on barriers to condom use were relevant to them. The resulting
intervention is extensive, tailored to individual needs and targets a wide set of influences on sexual health.
This is in line with recommendations that sexual health interventions should use a holistic approach to
sexual health and well-being.12
As with many complex interventions, the Men’s Safer Sex website contains multiple components, targeting
a number of influences on behaviour. Therefore, it can be difficult to determine which part(s) of the
intervention are effective and via which mechanisms. Online interventions offer the possibility of easily
monitoring patterns of intervention use, which can facilitate the analysis the mechanisms of action of an
intervention. Furthermore, clearly describing the intervention aims and content assists in this analysis. BCTs
provide a standardised method for this process of describing intervention content.
The utility of the Behaviour Change Wheel
The BCW provided a useful and manageable framework for integrating information from multiple sources
to design an intervention, especially for organising the information conceptually, for guiding the process of
identifying influences on behaviour, and for selecting and delineating standardised methods for targeting
those influences.
The advantage of using an integrative theoretical framework, such as the TDF, over a single theory of
health behaviour is that they encompass multiple explanatory domains and, therefore, provide a more
comprehensive assessment of factors which are important to the target population.23 This is illustrated in a
recent review of theories of behaviour change which found that only 3 out of 83 theories were integrative
and set out to be comprehensive.62,63 Models such as the Theory of Planned Behaviour64 present a cognitive
model of behaviour (attitudes, perceived norms and perceived behavioural control predict intentions which,
in turn, predict behaviour), downplaying impulsive factors in decision-making, which may influence
motivation (an important influence on behaviour). Beyond identifying potential influences on behaviour,
the BCW also provides structured guidance for determining the content and format of interventions.
Although the TDF is helpful in that it offers an extensive list of potential influences on behaviour, some
domains were difficult to conceptualise within this context. ‘Goals’ was included as an important domain, but
largely as a method of encouraging people to implement the advice given in the website and to target other
domains (such as memory, attention and decision processes). Although the aim of the intervention was to
improve intention, this was approached by targeting other domains. The TDF is a framework, rather than a
theoretical model, and so does not specify causal pathways between variables. The intervention developer must
draw on other evidence and theories to decide and elaborate on potential relationships between variables.
The use of standardised BCTs to specify the intervention content provided two advantages. First, the BCTs
provided ideas for website features and health promotion messages (so the authors did not start with a
‘blank canvas’). Second, the BCTs were used to specify the content in standardised terms to facilitate
replication, judgements regarding quality and comparisons with other interventions.30 Translating BCTs into
interactive website features can be a difficult process and requires a certain level of creativity. Given that
the content of complex interventions is often not described in detail,20 building a repository of examples of
such features would be a valuable resource for intervention designers.
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The study had some limitations. For example, although we collected detailed data to specify intervention
content, the literature review was targeted, rather than fully systematic, owing to time and resource
constraints. This means some relevant evidence may have been missed; however, the inclusion of a
number of reviews in the literature review mitigates this concern. A second limitation is that all men
interviewed during the development process were sampled from sexual health clinics within inner London,
thus potentially limiting the transferability to other populations and settings. However, the findings from
our literature review confirmed the importance of the emergent themes from the interviews.
This chapter has provided a detailed description of an evidence-based IDI for sexual health, including how
BCTs were translated into practice within the design of the Men’s Safer Sex website. It is hoped that this
will assist intervention developers in their development work and reporting in terms of BCTs.
INTERVENTION DEVELOPMENT
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Chapter 3 Feasibility randomised controlled trial
of the Men’s Safer Sex website
Introduction
Interactive digital interventions are effective for improving knowledge12,16 and can improve sexual
behaviour (including condom use),12,16 but more evidence is needed to establish effects on biological
outcomes, such as STIs, and cost-effectiveness. We planned to conduct an online randomised controlled
trial (RCT) in sexual health clinic settings, offering the Men’s Safer Sex website on an iPad® (Apple Inc.,
Cupertino, CA, USA) to men in clinic waiting rooms. However, it can be difficult to recruit people to trials
in clinical settings and to retain participants in online trials.14 This feasibility trial was designed to evaluate
retention rates and methods of outcome measurement for costs and sexual health outcomes (self-reported
online and using clinic records).
Aims
To establish the feasibility and optimal design of a full-scale RCT to test the effect of the Men’s Safer Sex
intervention website on condom use and STI acquisition in men attending sexual health clinics.
Methods
Design
This study is a feasibility RCT with random allocation to the Men’s Safer Sex website plus usual sexual
health clinical care compared with usual sexual health clinical care only.
Participants and setting
Participants were recruited from three English sexual health clinics, two in central London and one in
the Midlands. These clinics were selected as they serve a diverse range of patients in terms of age,
socioeconomic status and ethnicity.
Inclusion criteria
l Men aged ≥ 16 years (with no upper age limit).
l Able to read English.
l Have access to the internet.
l At a high risk of future STI [i.e. two or more partners in the past year (male or female) and non-condom
use in the past 3 months, or symptoms of suspected acute STI, or seeking treatment for a STI].
l For whom at least half of their sexual partners are female.
Exclusion criteria
Men who were HIV positive and men with hepatitis B or C were excluded, as patients with these
diagnoses are likely to receive more intensive input in the course of routine clinical care. Men who had
ever had sexual experiences only with other men, men who had sexual experiences more often with males
but at least once with a female, or men with no sexual experience at all65 were also excluded.
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Procedure
Research procedures were conducted online: a tablet computer (iPad) was positioned in the sexual health
clinic waiting rooms or a side room. Leaflets and posters advertised the study and invited potential
participants to approach the iPad (see Appendix 7); research and clinic staff also directed patients towards
the iPad. Enrolment was self-directed, with staff available to help with technical problems. Trial software
on the iPad guided participants through eligibility questions, informed consent and baseline demographic
and outcome questions (see Appendices 8–10). Most online questions were compulsory and free-text
comment boxes were offered at the end of groups of questions. All participant data were stored online
using secure external servers. Following completion of baseline questionnaires, an automated computer
algorithm allocated participants randomly either to the control group (at which point they were thanked
for their time and asked to log out) or the intervention group (at which point they were directed to the
intervention website). Those allocated to the intervention group were asked to engage with the Men’s
Safer Sex website for as long as they wished (usually until the point at which they were called in to see
health professionals). They also had access to the website by logging in after leaving the clinic.
Intervention
Participants in the intervention group were invited to interact with the Men’s Safer Sex intervention website
while in the clinic waiting room. The time available for this varied by participant but we expected that
participants would have an average of 10 minutes to interact with the intervention. Participants in the
intervention group were also able to access the intervention website after leaving the clinic, for the duration
of the follow-up period (12 months), using a username and login that they had chosen. Monthly e-mails
were sent to participants in the intervention group, reminding them to visit the website, giving ‘teaser’ web
links to intervention content. In addition, participants received e-mails reminding them about goals they had
set on the website (see Chapter 2).
At 3, 6, 9 and 12 months after their initial clinic visit, participants were invited via e-mail to complete an
online follow-up questionnaire. If they did not initially complete the questionnaire, they received three
further e-mail prompts, at 1-week intervals, as well as two short message service (SMS) messages to their
mobile phone (again, including the web link) at 1-week intervals alongside the previous two e-mails. If
participants still did not respond, the researcher telephoned them 1 week after the final e-mail and SMS,
reminding them about the questionnaire. Participants were given a 7-week window to complete their
questionnaire. This window was extended at 3 months (until the 6-month questionnaire was due)
in order to maximise responses, as technical issues had caused participants some difficulty in logging in.
Information about STI diagnoses were collected at all time points via self-report and at 12 months by
recording diagnoses or suspected diagnoses over the past 18 months (to control for pre-baseline service
usage) recorded in the clinical notes at the sexual health clinics that participants were recruited from.
Outcomes
We adapted the Sexunzipped online sexual health questionnaire66 to measure outcomes and mediators of
condom use. We selected items for inclusion based on a literature search for established measures and
consultation with experts. Interviews were conducted with men in sexual health clinics (n = 11) to gain
feedback on successive versions of the outcome questionnaire.
In the light of evidence that measurement alone may prompt behaviour change,67,68 a limited number of
outcomes were measured at baseline (condom use and the main mediators, and self-reported STI
diagnoses) and a full range of outcomes were assessed at 3, 6 and 12 months (Table 4). The primary
feasibility outcome was retention in the study at 3 months, which was measured by response to the
3-month online questionnaire. The main behavioural outcome of interest was self-reported number of
episodes of condomless sex at the 3-month follow-up. All self-assessments had a recall period of the
previous 3 months. A full copy of the follow-up questionnaire (which assessed all outcomes) can be found
in Appendix 7.
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Questions at baseline included demographic information including age, employment status and ethnicity.
Condom use
The objective of the study was to promote condom use with female partners and so the primary outcome
was the number of episodes of condomless vaginal or anal sex over the previous 3 months, assessed at the
3-month follow-up. It was expected that the majority of change in behaviour would occur shortly after
recruitment, as it was expected that users would be most likely to engage with the intervention during
the clinic visit. The published protocol69 stated that the primary outcome was episodes of condomless
vaginal sex only; however, during revisions to the questionnaire (to reduce the length in response to user
feedback) questions regarding episodes of vaginal and anal sex were combined into one question. This
combined item was therefore used as the main outcome of interest. The number of partners that
participants had condomless sex with over the previous 3 months was also assessed – female (vaginal and
anal sex) and male (anal sex).
Sexual partners
Participants were asked to report the number of sexual partners over the past 3 months (both female
and male).
TABLE 4 Variables assessed at each time point
Baseline measures 3-, 6- and 12-month follow-up assessments
Demographic details (age, occupation, ethnicity)
Sexual health outcomes
Sexual partners Sexual partners
Condom use: episodes and partners Condom use: episodes and partners
Self-reported STI diagnoses Self-reported STI diagnoses
Contraception use and pregnancy Contraception use and pregnancy
HRQoL (EQ-5D-3L) HRQoL (EQ-5D-3L)
Service use
SQoL SQoL
Mediators of condom use
Motivation to use condoms Motivation to use condoms
Intentions to use condoms Intentions to use condoms
Beliefs about pleasure Beliefs about pleasure







EQ-5D-3L, European Quality of Life-5 Dimensions, three-level version; HRQoL, health-related quality of life;
SQoL, Sexual Quality of Life.
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Contraception use and pregnancy
Participants were asked to indicate which types of contraception (if any) they were using with current
partners. Participants were asked whether or not a female partner had been pregnant in the past 3 months
and the outcome of that pregnancy.
Sexually transmitted infection diagnoses
Participants were asked to report acute STI diagnoses over the past 3 months at every follow-up point.
Participants were also asked whether or not they had received treatment owing to a partner being
diagnosed with a STI. In order to assess laboratory diagnoses, all STI diagnoses recorded in sexual health
clinic records (in the participating sites) over the study period were noted at 12 months.
Health-related quality of Life
Health-related quality of life (HRQoL) was assessed using the European Quality of Life-5 Dimensions,
three-level version (EQ-5D-3L)70,71 which is a 5-item, 3-level questionnaire covering self-care, usual activity,
anxiety and depression, pain and mobility. A newly developed SQoL questionnaire72 was also used, in order
to compare its performance with the EQ-5D-3L to assess its suitability for outcome assessment in a sexual
health context.
Service use
Use of various sexual health services (e.g. sexual health clinics, general practice, outreach services) over the
study period was assessed by self-report.
Engagement with the intervention (patterns of website use)
Website usage (times the website was visited, pages visited) was recorded in order to assess engagement
with the intervention.
Adverse effects
Participants were asked to report whether or not they experienced any adverse effects as a result of the
study, recording this in a free-text box on each of the follow-up questionnaires (at 3, 6, 9 and 12 months).
Mediators of condom use
Although it is important to assess changes in behaviour, it is also important to assess the mediators of
behaviour change to provide information about the mechanisms by which behaviour might have changed.
The mediators measured determinants of condom use that were specifically targeted within the
intervention, identified using the theoretical frameworks of the COM-B model23 and the Plans, Responses,
Impulses, Motives and Evaluations (PRIME) theory of motivation.56
Condom-use errors and problems
To assess any impact on condom-use skills, condom-use problems were assessed at all time points, using a
measure defined by Crosby et al.,37 which assesses the occurrence of 15 condom errors and problems
within the past 3 months. The scale was adapted in the light of qualitative fieldwork to improve relevance
and understanding.
Knowledge
Knowledge (of risk of STIs and condom sizes) was assessed using an 11-item measure, devised based on
gaps in men’s knowledge identified in the literature69 and in interviews with the target population during
the development of the intervention. A number of ‘true or false’ statements regarding misconceptions
about condoms and risk were given (e.g. ‘You would know if you had a STI, without needing a test’).
Communication with partners
To assess communication with partners over a 3-month period, the 6-item Partner Communication Scale
was used.73 The scale was adapted in the light of qualitative fieldwork and the recall period was modified
from 6 months to 3 months in line with all other assessments.
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Identity
To assess potential links between identity (self-perception) and condom use,56 a 7-item scale was created,
derived from issues relating to condom-use identity that had arisen during the fieldwork.
Beliefs about pleasure
Beliefs about pleasure were assessed using an 8-item scale, adapted from the ‘Effect of sexual experience’
subscale of the Condom Perceived Barriers Scale.74 The scale was adapted in the light of qualitative
fieldwork to improve relevance and understanding.
Self-efficacy
Self-efficacy was assessed using a 14-item measure, adapted from the widely validated Brafford and Beck
scale.75 The scale was adapted in the light of qualitative fieldwork to improve relevance and understanding.
Motivation, intention and evaluation of condom use
Motivation (want) and intention to use condoms, and evaluation of condom use, were assessed using
single-item measures (Robert West, University College London, 12 September 2013, personal
communication).
Alcohol and drug use
A single item assessing the number of times in the past 3 months participants had condomless sex when
intoxicated was included.
Data from medical records
Participants were asked to provide consent to access their medical records held at the sexual health clinic
from which they were recruited from the study. A study researcher located files from patient records,
collecting information for sexual health clinic attendances 6 months prior to participants’ date of
recruitment to the trial and for the duration of the trial. Data were recorded on a Microsoft Excel® 2010
(Microsoft Corporation, Redmond, WA, USA) spreadsheet with no participant identifiable information
included; the unique participant identifier linked the clinic data to participant questionnaire data.
Sample size
This was a pilot RCT with a primary aim of assessing the success of recruitment and retention, engagement
with the intervention and the acceptability of trial procedures to participants and clinic staff. The possible
effect size of key outcomes, including condom use over the past 3 months, were assessed to inform power
calculations for a future Phase III RCT.
Power calculations were performed based on data from the Sexunzipped online trial.66 The study was
powered to allow estimates of the effect of the intervention on episodes of condomless vaginal sex over the
past 3 months. A sample size of 166 (intervention, n = 83; comparator, n = 83) randomised 1 : 1 between
experimental and control conditions is adequate to detect a reduction of 1.35 episodes of condomless sex
with a conventional two-sided α of 0.05 and 90% power (1 – β). Allowing for potential loss to follow-up at
3 months, 122 participants (intervention, n = 61; comparator, n = 61) is adequate to find a reduction of 1.35
episodes of condomless sex with a conventional two-sided α of 0.05 and 80% power (1 – β). In addition,
this sample size is also sufficient to detect a 1.65 difference in safer sex intention and a 1-point difference in
self-efficacy on Likert scales, with a conventional two-sided α of 0.05 and 90% power (1 – β). A total of
176 participants were randomised and, after later exclusions and withdrawals, 159 remained.
Randomisation
Once participants had been checked for eligibility, given informed consent and submitted baseline data,
they were allocated 1 : 1 using a computer algorithm randomisation system to either the intervention or
control group. The allocation was automated and instant and, therefore, was concealed until the point of
allocation. Participants were informed with an automated message on the iPad and this allocation
was unalterable.
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Blinding
It was not possible to blind participants to their allocation, as those in the control condition did not receive
access to any website. Research staff (including those conducting the analysis) were blind to allocation
condition, as allocation was performed using the software on the iPad; however, the researcher
performing recruitment may have been aware of allocation owing to the amount of time participants
spent on the iPad. Allocation was revealed only once statistical analyses were complete.
Statistical methods
We present descriptive statistics by group at baseline and follow-up for main and secondary outcomes. The
treatment effect at follow-up was estimated using generalised linear models with a loge link and Poisson
error. The loge of the baseline values were included in each model as explanatory variables to account
for baseline differences. Standard errors were estimated using variance components to account for
overdispersion in the models. Incidence rate ratios (IRRs) comparing the control with intervention groups
were estimated from these models along with their 95% confidence intervals (CIs) and p-values.
Results
Recruitment
Participants were recruited between 28 April 2014 and 7 July 2014. Follow-up data were collected
between 28 July 2014 and 2 July 2015. Recruitment ceased once target numbers were reached.
Participant flow is outlined in Figure 7. Owing to a technical error in the online recruitment software,
reasons for exclusion were available only for 20 participants.
One hundred and seventy-six participants were randomised, of whom seven withdrew from the study, one
was a duplicate account and nine were withdrawn owing to being later found to be ineligible (they had
been erroneously classed as eligible because of a technical error in the eligibility screening questionnaire).
Fifty-five responded to the baseline questionnaire and the 3-month follow-up questionnaire (the principal
outcome point) (22 in the control group, 33 in the intervention group). Forty-six participants responded to
the baseline questionnaire and to all three follow-up questionnaires (27 in the control group, 19 in the
intervention group). Data on STIs from clinic records were available for 149 (93.7%) participants. We
monitored free-text comments on the online outcome questionnaires and found no reason to terminate
the trial early. We did not conduct interim data analyses as the primary aim was to assess retention at
follow-up.
Participants
Characteristics of participants are shown in Table 5. The mean age of participants is in line with data that
suggest people in the 25–34 years age bracket are more likely to attend STI testing76 and employment
status and ethnicity were comparable with the general population.77,78
Website usage
Thirty-seven per cent of participants in the intervention group visited the Men’s Safer Sex website once
(n = 31/84), 26% more than once (n = 22/84) and 37% did not see the Men’s Safer Sex website at all
(n = 31/84). Twenty-two participants (26%) returned to the website after leaving the clinic, with most of
these participants logging into the website twice in total (n = 13/22). The maximum number of return visits
was eight. Participants visited a median number of 15 pages out of a maximum of 35 main topic or
activity pages.
Descriptive statistics
Distributions of outcomes for condom use, self-reported STI and mediators of behaviour change are
reported in Tables 6 and 7.
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(n = 16 of 20 screened)
• Aged < 16 years, n = 0
• More than half of partners were male, n = 3
• No risky behaviour or suspected STI, n = 9
• No internet access, n = 4
• Had HIV or hepatitis, n = 2
• Some participants met more than one 
   exclusion criterion
FIGURE 7 The Consolidated Standards of Reporting Trials diagram showing flow of participants.
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TABLE 5 Baseline demographic characteristics of participants
Demographic characteristic Intervention, n (%) (N= 84) Control, n (%) (N= 75)
Age (years), mean (SD) 29.3 (8.8) 29.5 (8.4)
Employment status
School/college/training 10 (11.9) 19 (25.3)
Working 61 (72.6) 49 (65.3)
Unemployed 11 (13.1) 5 (6.7)
Long-term sick or disabled 1 (1.2) 0 (0)
Other 1 (1.2) 2 (2.7)
Ethnicity
White British/Irish/other 60 (71.4) 50 (66.7)
Black British/Caribbean/African/other 11 (13.1) 12 (16.0)
Asian British/Indian/Pakistani/Bengali 4 (4.8) 4 (5.3)
Chinese/other Asian 2 (2.4) 2 (2.7)
Mixed cultural background 4 (4.8) 4 (5.3)
Other 3 (3.6) 2 (2.7)
Prefer not to say 0 (0) 1 (1.3)
SD, standard deviation.
TABLE 6 Condomless sex and STI diagnoses at baseline and follow-up
Sexual health outcome
Control (n= 75) Intervention (n= 84)
Q1 Med Q3 Maximum n Q1 Med Q3 Maximum n
Episodes of condomless vaginal or anal sex with a woman in past 3 months
Baseline 2 6 20 50 72 1 4 20 155 72
3 months 3 12 30 100 34 2 10 40 100 23
Number of female condomless sex partners in 3 months
Baseline 1 1 2 15 72 1 1 2 20 72
3 months 1 1 2 6 34 1 1 2 15 23
Number of male condomless anal sex partners
Baseline 0 0 0 0 72 0 0 0 3 72
3 months 0 0 0 1 34 0 0 1 3 23
STIs (clinic notes)
Baseline 0 0 1 3 69 0 0 1 2 80
12 months 0 0 0 4 69 0 0 0 2 80
Self-reported STI (online)
Baseline 0 0 0 2 72 0 0 0 1 72
3 months 0 0 0 1 34 0 0 0 1 23
Med, median; Q1, lower quartile; Q3, upper quartile.
Data are presented as medians and interquartile ranges, as the data were highly skewed.
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Group comparisons for condomless sex and sexually transmitted infections
Measures of condomless sex with female and male partners were not significantly different between the
intervention and control groups at 3 months (Table 8). Twenty-three diagnoses of acute STI (one or more
over 12 months) were recorded in the clinical notes of 15 trial participants (non-specific urethritis, n = 7;
Chlamydia trachomatis, n = 7; Neisseria gonorrhoeae, n = 3; epididymitis, n = 2; molluscum contagiosum,
n = 2; and people treated as contacts of someone with chlamydia, n = 2). New acute STI diagnoses were
TABLE 7 Sexual health outcomes at baseline and follow-up
Sexual health outcome
Control (n= 75) Intervention (n= 84)
Q1 Med Q3 Maximum n Q1 Med Q3 Maximum n
Number of female partners in 3 months
Baseline 1 3 4 179 72 1 2 4 55 72
3 months 1 2 3 18 34 1 1 4 23 23
Number of male partners in 3 months
Baseline 0 0 0 5 72 0 0 0 15 72
3 months 0 0 0 0 34 0 0 0 4 23
Episodes of condomless sex owing to being drunk/having taken recreational drugs in 3 months
Baseline 0 0 2 20 72 0 0 1 30 72
3 months 0 0 3 25 34 0 0 1 5 23
Self-efficacy score
3 months 36 40 45 50 (range 10–50) 33 40 44 46 50 21
Pleasure score
Baseline 21 25 29 38 (range 9–45) 72 19 24 31 41 72
3 months 20 24 27 32 (range 9–45) 34 21 25 30 36 23
Number of condom problems in the past 3 months
3 months 1 2 4 8 (range 0–14) 34 1 2 3 5 23
Motivation
Baseline 2 3 4 4 (range 1–4) 71 2 3 4 4 69
3 months 2 3 4 4 (range 1–4) 32 1 3 3 4 21
Intention
Baseline 2 3 3 4 (range 1–4) 68 2 3 4 4 67
3 months 2 3 3 4 (range 1–4) 32 1 3 3 4 21
Evaluation of condom use
3 months 3 4 4 4 (range 1–4) 34 4 4 4 4 22
Knowledge score
3 months 8 9 10 11 (range 0–11) 34 9 10 11 11 23
Communication score
3 months 0 2 4 5 (range 0–5) 34 1 2 4 5 23
Identity score
3 months 25 27 29 35 (range 7–35) 34 25 28 30 35 23
Med, median; Q1, lower quartile; Q3, upper quartile.
Data are presented as medians and interquartile ranges, as the data were highly skewed.
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recorded for 8.8% (7/80) of men in the intervention group and 13.0% (9/69) in the control group over the
course of 12 months. The IRR indicated a 25% lower cumulative incidence in the intervention group than
the control group, but this was not a significant difference (IRR 0.75, 95% CI 0.29 to 1.90).
Discussion
In this pilot trial we explored the feasibility of a full-scale online RCT (in sexual health clinic settings) of the
Men’s Safer Sex website for MSW. Recruitment into the trial was a success: the target sample size was
achieved within 2 months, with the highest rates of recruitment on days when a researcher was present to
remind staff and patients about the study. Retrieval of clinic records for clinical STI diagnoses was excellent
(94%); however, response rates for online outcome measurement were poor (36–50%) despite a number
of strategies to improve follow-up, including offers of incentives, repeated e-mail prompts, text messages
and telephone calls. There were no reported harmful effects from the Men’s Safer Sex website or online
trial. We discuss the implications of this feasibility trial for the conduct of online trials of digital interventions
in sexual health clinic settings.
Problems with software and patient Wi-Fi access
We encountered technical issues at all time points which hampered recruitment and registration,
participant access to the Men’s Safer Sex website, online data collection and retention of men in the trial
at 3-, 6- and 12-month follow-up points. The NHS lags behind many other institutions in terms of patient
access to digital services;79 therefore, it was difficult to set up and maintain access to Wi-Fi for patients in
clinic waiting rooms because the process for permission and set up was complicated, connections were
often poor and staff were not always confident about remedying internet access problems.80
There were substantial software development errors that had an impact on recruitment of eligible
participants as well as data collection and access to the intervention (e.g. errors with links to the outcome
questionnaire, login and password reset functions). Despite careful specification of requirements for the
project, there were delays to intervention development, there was a faulty algorithm for participant
selection, user experience of the website was not always positive, there was failure of automated analytic
data collection, and the login/website access was occasionally faulty. Despite careful specification of
requirements, and extensive manual testing by the research staff, the time available for automated testing
TABLE 8 Group comparisons for condomless sex and STI diagnoses
Outcome
Baseline Follow-up













Number of times had
condomless sex with a
woman (in 3 months,
at 3-month follow-up)
6 (72); 2,20 4 (72); 1,20 12 (34);
3,30





with (in 3 months, at
3-month follow-up)
1 (72); 1,2 1 (72); 1,2 1 (34); 1,2 1 (23); 1,2 1.09 0.69 to
1.71
0.712 55
Number of men had
condomless sex with
(in 3 months, at
3-month follow-up)





notes (over 1 year, at
12-month follow-up)
0 (69); 0,1 0 (80); 0,1 0 (69); 0,0 0 (80); 0,0 0.75 0.29 to
1.90
0.543 149
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and user testing was severely reduced and the extent of these problems was realised only after patients
had been recruited. Reliable software frameworks for online RCTs are needed, which are customisable,
user-friendly and which meet requirements for secure data protection and data storage.
Ethical issues
It is essential that participants in research are given the information that they need to give informed
consent and that confidentiality and data security are ensured.81 However, we encountered are several
tensions between these principles and the practical realities of (online) research.
Informed consent and the online environment
We required potential participants to establish their eligibility (through responses to nine online questions),
to read study information online (see Appendix 6), indicate agreement on the consent form, create a
unique account with a secure password and then respond to demographic and sexual health questions
before being offered access to the intervention website. Ethics committees require careful explanation,
in writing, to participants regarding what is involved in the research; however, we found that research
participants might not read this in detail82 and, instead, make judgements based on their trust in the
researchers, for example.68 Users do not like large amounts of text online79,83 and we found that research
participants did not read the information pages in detail. Furthermore, some participants appeared to be
annoyed by the online research procedures (see Chapter 5).
Privacy and data security
The online environment opens up the potential for irreversible breaches of privacy and data security.81
University College London (UCL) information governance protocols required users to select passwords that
are hard to guess, but this also makes passwords harder for participants to remember. The software security
protocol also led to frustrating problems, for example a password would be rejected as ‘not matching’ if
participants had entered a space at the end of the password on one occasion and not another.
Most e-mail accounts are not secure (i.e. can be hacked) and it is also a risk that someone’s e-mails or
texts may be read by another person on a mobile phone or on computer. Other people would be able to
see a participant’s website browsing history unless they had chosen to delete or hide this. There were
concerns that this type of breach of privacy could reveal that a participant had been to a sexual
health clinic.
We met the requirements for informed consent and data security, but one-third of the intervention group
did not actually see the Men’s Safer Sex website (37%), which may have been because of the time taken
on enrolment and research procedures and/or being called in for appointments (see Chapter 5).
We found that participants were not particularly concerned about consent and confidentiality, and there
were no adverse events reported which related to consent or confidentiality (see Chapter 5). Participants’
trust was enhanced by the fact that this research was conducted by a university (UCL) in partnership with
the NHS and participants did not necessarily wish to have detailed information regarding the research.
It may be feasible to reduce burden on research participants through solutions such as offering bullet point
summaries of study information online, with links to full information for those who would like it, and
making clear the nature of the potential risks of online research. The online research environment is
relatively novel and protocols for secure data handling are evolving. It would be useful for stakeholders,
including researchers, funders and ethics committees, to consider the particular context of a digital
environment on the ethical principles of respect for individual autonomy and dignity, to maximise benefits
and minimise harm.81 When there are risks, the nature of these risks can be outlined for participants,
allowing participants to judge for themselves whether or not these are acceptable.
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Engagement with the Men’s Safer Sex website
Engagement with digital interventions for health promotion can be a major challenge.84 We placed the
intervention in clinic waiting rooms to take advantage of the waiting time that is common in drop-in
sexual health clinics; however, this depended on flow of patients into the clinic. One-third of the
intervention group did not see the Men’s Safer Sex intervention website, which may have been a result of
lack of available time. We shortened the length of the outcome questionnaire by capturing only key
outcomes at baseline, but the research procedures still took time (especially if participants were affected by
the technical problems described in Problems with software and patient Wi-Fi access).80
We sent e-mails at 1-month intervals to prompt men to access the intervention and one-third of
participants did visit the website after their initial clinic visit. We expected that the main opportunity for
intervention would be at the time of a clinic visit but, as discussed above, the time available for this was
limited. We offered financial incentives for follow-up data collection but not for engagement with the
intervention itself. The best methods for engagement need to be established, for example integrating the
Men’s Safer Sex website as a step in the patient pathway through the clinic.79
Sexually transmitted infection diagnoses in clinic records
We located clinic records with usable data on STI diagnoses for 94% of participants, searching by names
given, date attended, e-mail address or telephone number. The location of data from clinic records could
be improved by requesting additional information from participants (e.g. date of birth, address, clinic
number); however, soliciting additional identifiable data may discourage some people from participating in
research.80 Almost half of the sample (72/159) returned to the same clinic within 1 year; however, rates of
STI acquisition and service use may have been underestimated as participants are free to attend other
sexual health clinics and/or their general practitioner (GP) and records are not shared between clinics. This
would undermine the validity of clinically recorded STI diagnosis as an outcome if patients in different
experimental conditions returned to the original clinic at different rates. It might be possible to capture STI
diagnoses made at other sites by using Hospital Episode Statistics and GP data. However, patients in sexual
health clinics can choose pseudonyms and may be wary about confidentiality.80
Recording STI diagnoses from clinical notes has several advantages over self-reported online outcome
measurement: clinic record data are not subject to recall bias or social desirability bias, and data collection
from records is cheaper in terms of researcher time and costs of participant incentives. In addition, filling
in a sexual health questionnaire may prompt participants to reflect on their behaviour (for both control
and intervention participants),68,80 potentially reducing the apparent effect of an intervention. Recording
diagnoses from clinic records allows collection of cumulative incidence of STI over time, which is likely to be
more accurate than self-reported outcomes. The cumulative incidence of acute STIs over 1 year was 9.4%,
which compares with an annual recorded rate of 0.85% for new STI diagnoses for men attending sexual
health services in England.85 We were therefore successful in recruiting men at substantial risk of STI.
Online outcome measurement
Online trials have a number of potential advantages including automated enrolment, randomisation, data
entry and reminders.79 Online questionnaires can capture internally valid data on a range of outcomes
including sexual well-being outcomes, which reflect participants’ priorities.68,86
However, although online recruitment can be good, there can be high drop-out rates which limit validity.79,87
The response rates for Men’s Safer Sex online questionnaires sent by e-mail were poor (maximum of 50%),
despite an increased level of incentive for the final questionnaire (£30 vouchers). We used evidence-based
methods to enhance retention, that is contacting participants multiple times via different routes (by
personalised e-mail, text message and telephone calls).66,87,88 However, we do not know whether or not
e-mails ended up in junk mail or how many participants were put off by the initial technical problems with
password access and malfunctioning links to the outcome questionnaire. The larger incentive offered at
12 months appeared to have a positive influence on the response rate (an increase from 36% to 50%),
which is in line with studies which tested the effect of larger incentives.66,89
FEASIBILITY RANDOMISED CONTROLLED TRIAL OF THE MEN’S SAFER SEX WEBSITE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
Conclusion
There are particular challenges for online trials of digital interventions which include ensuring the reliability
of software, data security, patient access to information technology (IT) in clinical settings and patient
engagement with digital interventions. We have shown that using STI diagnoses from clinical records as a
biological outcome is feasible, but that it is challenging capturing self-reported outcomes, which limits
exploration of the mechanism of action of an intervention and measurement of sexual well-being. An
implementation study is needed to work out how best to maximise engagement with the Men’s Safer Sex
intervention (e.g. integrating it into routine clinic pathways and procedures). In conclusion, it is feasible to
conduct a future large-scale RCT to assess the impact of the Men’s Safer Sex website on STI acquisition
(recording clinic diagnoses as a primary outcome), but is not feasible at present to collect reliable online
self-reported data to analyse intervention mechanism of action.
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Chapter 4 Economic evaluation
Aim of Men’s Safer Sex economic evaluation
1. To inform the methods for collecting and analysing cost and outcome data for a cost-effectiveness
analysis alongside a Phase III trial.
2. To indicate whether or not the intervention seems promising with regard to cost-effectiveness.
Analyses
A cost–utility analysis is the analysis preferred by NICE for the economic evaluation of new technologies
[calculating the incremental cost per quality-adjusted life-year (QALY) gained for intervention compared
with control]. Using standardised methods to calculate QALYs is recommended to facilitate the comparison
of the results of health economic evaluations across disease areas and programmes of work.90 Recent
guidance from NICE and other experts has recognised that some interventions, particularly those aimed at
the primary prevention of disease, may not be suitable for cost per QALY analysis and have recommended
other methods, such as reporting of costs alongside outcomes, also known as cost–consequences
analysis.91,92 This increases the ability to show the impact of an intervention on a wider range of outcomes
compared with impact on costs. The feasibility and suitability of using QALYs in digital media interventions
of sexual health promotion has not been tested in previous studies.79 The Men’s Safer Sex study presented
an opportunity to assess the implications of the calculation of QALYs as part of an economic evaluation of
a digital intervention for STI prevention and improved condom use.
Because health economic evaluations that calculate cost–utility in the area of STI prevention are rare, there is
little known about the best way to collect QALYs.79 As a result, utility scores to calculate QALYs were collected
using two different questionnaires: (1) a generic preference-based measure of HRQoL, the EQ-5D-3L,93 and
(2) a sexual health-specific HRQoL measure – the Sexual Quality of Life (SQoL questionnaire).72 Specifically, a
simplified version of the SQoL questionnaire, the Sexual Quality of Life 3 Dimensions (SQoL-3D), was used in
the study. The SQoL-3D was chosen as a measure of sexual quality of life because it has an associated
preference-based tariff that can be used to calculate QALYs for economic evaluations. Sexual quality of life
was evaluated on the premise that the improvement of sexual knowledge and behaviour may also improve
sexual quality of life, something that is not specifically measured as part of the EQ-5D-3L.
Sexual health-related health-care resource use and a health-care cost perspective were also collected from
two sources: (1) self-reported questionnaires completed at 3, 6, 9 and 12 months and (2) data collected
from participant sexual health clinic medical records (see Chapter 4). To investigate the impact on the
results of a cost–utility analysis of using different questionnaires to calculate utilities and QALYs, and
using different methods to collect resource use, five cost-effectiveness analyses have been conducted:
1. EQ-5D-3L and self-completed questionnaires for resource use
2. SQoL-3D and self-completed questionnaires for resource use
3. disutility of a STI and resource use from participant sexual health clinic medical records
4. cost per STI prevented using self-completed questionnaire responses for resource use
5. cost per STI prevented using participant sexual health clinic medical records for resource use.
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Calculating quality-adjusted life-years
For analyses 1 and 2 described above, individual-level utility scores were calculated from individual
responses to the EQ-5D-3L and the SQoL-3D at baseline and at 3, 6, 9 and 12 months. EQ-5D-3L utility
scores are calculated using the algorithm published by Dolan94 and the SQoL-3D using the rescaled utility
algorithm, for which death equals zero, published by Ratcliffe et al.72 Patient-level QALYs were calculated
as the area under the curve using the methodology described in Hunter et al.95 for complete case analysis,
adjusting for baseline values. CIs were constructed using bootstrapping and 1000 iterations.
To assess the suitability of the EQ-5D-3L and SQoL-3D for calculating QALYS in sexual health digital
interventions, linear regression models were fitted to evaluate whether or not there is a significant
relationship at p < 0.05 between individual-level utility scores and QALYs compared with any instances of
condomless sex and STI diagnosis.
Analysis 3 (disutility of a STI and resource use from participant sexual health clinic medical records),
evaluated the feasibility and impact of calculating the cost-effectiveness of the Men’s Safer Sex
intervention using patient files. Data from the trial were used to calculate the 1-year disutility of having a
STI using simple linear regression fitted to complete case QALYs calculated from the EQ-5D-3L. A
coefficient was included for STI at baseline compared with no STI at baseline to calculate the disutility.
Owing to the small number of participants diagnosed with a STI and who had complete EQ-5D-3L data,
STI-specific disutility could not be calculated.
Participant clinical files were used to identify participants with STIs over the 12 months’ follow-up. It was
assumed that all participants have the mean utility score except for participants who have a STI. A
12-month disutility for having a STI is then applied to any patients diagnosed with a STI during the
12-month follow-up.
Sexually transmitted infection-related health-care resource use and costs
Participants completed questionnaires on sexual health-related resource use at 3, 6 and 12 months.
Differences in resource use at each follow-up point between groups have been tested using the chi-squared
test and any significant differences at an α < 0.05 reported. Unit costs applied to resource use and their
sources are reported in Table 9. It was not possible to tell whether or not STI tests and treatment occurred in
the same or different appointments, so it was assumed that a blood test, urine test and swab would all
occur in the same appointment and then additional appointments were counted for each subsequent time
TABLE 9 Unit costs
Resource Cost (£) Reference
Condom pick-up (assumed three condoms per pack) 2 Boots (Nottingham, UK)96
Self-test kit for STIs 16.50 (test kit), 2 (postage) NICE2
GP appointment 46 (including qualifications) Curtis97
Sexual health clinic appointment (half of appointment
with the nurse and half with the consultant)
105 Department of Health98
Urine test 16 NICE2
Blood test 2 Department of Health99
Treatment (weighted for prevalence of chlamydia and
warts in files)
11 BNF100
Sexual health advice: primary care or sexual health clinic 20 NICE2
Sexual health counselling sessions 47 NICE101
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they had had the same test. Furthermore, the assumption was made that treatment happened in an
additional appointment. For example, if a participant had two urine tests and one blood test but received
treatment once, it was assumed that they had attended three appointments – two for the tests (one for
each test type) and one for the treatment. For sexual health advice, this was added on as an additional
£20 per instance in line with the NICE costing template for sexual health services.1
Mean total cost per patient at each follow-up point has been calculated and reported for complete cases
(questionnaire completion at all follow-up points). In addition, 95% CIs have been calculated using
bootstrapping and 1000 iterations.102 No baseline resource use data were collected via patient questionnaires
so as to maximise the amount of time participants in the intervention group could spend on the intervention.
As a result, sexual health-care resource use collected using questionnaires could not be adjusted for baseline
differences between groups.
Data from participant clinical records were used to calculate (1) the cost of the appointment that directly
followed recruitment to the trial and (2) the cost of any follow-up appointments that occurred between
recruitment and follow-up. Information on appointments that occurred during the 6 months prior to
recruitment was used to adjust for differences in resource use using regression analysis. Costing was
carried out using a bottom-up approach costing for clinician time (including on-costs and overheads),97
diagnostic tests2,99 and medication.100
All costs are reported as 2014 values. Costs prior to 2014 were inflated to 2014 values using the hospital
and community health services index.97
Cost of the intervention
The total cost of developing and maintaining the intervention website was collected as part of the project
management of the trial. There is no definitive way to incorporate the cost of a digital intervention into an
economic evaluation.79 The complications with doing so are the result of a number of factors, including
(1) the intervention has now been developed and, hence, could be considered a ‘sunk cost’ as no further
costs are required to develop it, (2) it is free to patients and providers at the point of access, (3) it is unclear
how many people will go on to use the site therefore the cost per patient is hard to calculate and (4) it may
be hard to disentangle costs associated with the trial (e.g. developing questionnaires and databases to store
trial-related data) from the costs of developing the intervention and day-to-day maintenance if it were to be
made widely available. As a result, we report the different costs associated with developing the website and
the number of individuals that accessed the website to give some estimation of cost per individual.
If QALY gains are seen in the intervention group compared with the control group, we can also report the
number of patients that would need to access the website for it to be cost-effective at the lower end of
the willingness-to-pay (WTP) threshold of £20,000 per QALY, which is the threshold generally deemed
likely for NICE to approve the implementation of an intervention.103
Incremental cost-effectiveness ratio
The mean costs and QALYs calculated above will be used to calculate the mean incremental cost per QALY
gained, known as the incremental cost-effectiveness ratio (ICER), of the website intervention compared
with control over the 12-month duration of the trial for all analyses specified above. The number of
infections prevented has been taken from the statistical analysis reported in Chapter 4 and used to
calculate the mean incremental cost per infection prevented.
Cost-effectiveness acceptability curve
A cost-effectiveness acceptability curve (CEAC) reports the probability that an intervention is cost-effective
compared with the control. This is based on running the analysis a number of times, in this case 1000
times using bootstrap sampling from the data collected and recalculating the statistic of interest, and
counting the number of times that the ICER is below the WTP threshold. This is divided by the number of
times the analysis has been run to give the probability. The results of the bootstrap were used to construct
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CEACs for a range of values of WTP for a QALY gained. The probability that the website is cost-effective
compared with the control at a WTP for a QALY gained of £20,000 is reported in Results.
Sensitivity analyses
The number of pregnancies (in female sexual partners) was also reported in the patient questionnaires.
These are rare and expensive events that may be hard to capture and could skew the results; therefore,
they have been included in the sensitivity analysis only. Only pregnancies after baseline were included
given no other cost information is available at baseline. All pregnancies after baseline were reported as
miscarriages which have an average cost of £551 per miscarriage.99 The sensitivity analysis was run using
the same methodology as above but including the cost of pregnancy.
Results
Completion of questionnaires
There was a large proportion of missing data owing to poor follow-up rates. Analyses have been
conducted on complete cases (follow-up data at 3, 6 and 12 months for costs and also including
information baseline for QALYs) in line with the statistical analysis plan and assuming that cases are
missing at random. The number of participants completing questionnaires at each time point and complete
cases are reported in Tables 10 and 11. From 72 participants in each group at baseline, there were 27
(37.5%) complete cases in the control group and 19 (26.4%) in the website intervention group.
TABLE 11 Questionnaire completion rates, utilities and QALYs using SQoL
Utilities Control group n, mean (SD) Website group n, mean (SD)
Baseline 72, 0.932 (0.043) 72, 0.935 (0.044)
3 months 34, 0.945 (0.037) 23, 0.941 (0.039)
6 months 35, 0.939 (0.046) 23, 0.928 (0.053)
12 months 43, 0.937 (0.047) 36, 0.939 (0.042)
Area under the curve Complete cases n, mean (SD) Complete cases n, mean (SD)
QALYs 27, 0.940 (0.032) 19, 0.936 (0.034)
QALYs (adjusted) 0.937 0.938
SD, standard deviation.
TABLE 10 Questionnaire completion rates, utilities and QALYs using EQ-5D-3L
Utilities Control group n, mean (SD) Intervention group n, mean (SD)
Baseline 72, 0.881 (0.160) 72, 0.868 (0.226)
3 months 34, 0.912 (0.129) 23, 0.900 (0.146)
6 months 35, 0.870 (0.205) 23, 0.884 (0.175)
12 months 43, 0.862 (0.248) 36, 0.905 (0.195)
Area under the curve Complete cases n, mean (SD) Complete cases n, mean (SD)
QALYs 27, 0.904 (0.113) 19, 0.902 (0.112)
QALYs (adjusted) 27, 0.886 19, 0.918
SD, standard deviation.
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Quality-adjusted life-years
Utility scores and QALYs calculated from responses to the EQ-5D-3L and the tariff developed by Dolan94
are reported in Table 10. There was no significant difference in QALYs between the two groups with an
adjusted difference of 0.03 for intervention minus control group (95% CI –0.02 to 0.08).
Utility scores and QALYs calculated from response to the SQoL questionnaire and the tariff developed by
Radcliffe et al.72 are reported in Table 11. There was no significant difference in QALYs between the two
groups with an adjusted difference of 0.001 for intervention minus control group (95% CI –0.02 to 0.02).
Table 12 reports the linear regression relationship between the EQ-5D-3L (index and QALY), any
condomless sex and STIs. Table 13 reports the linear regression relationship between the SQoL-3D
(index and QALY), any condomless sex and STIs. The only statistically significant relationship at p < 0.05 is
between QALYs and STIs at baseline using the EQ-5D-3L.
TABLE 13 Linear regression coefficient for the relationship patient-level utilities, QALYs calculated using the


















3 months –0.029 –0.027
6 months 0.014 0.015
9 months –0.002 –0.009
STI at baseline
(clinic notes)
–0.006 0.004 0.003 –0.011 –0.001
STI at 9 months
(clinic notes)
–0.029 0.0005
TABLE 12 Linear regression coefficient for the relationship patient-level utilities, QALYs calculated using the


















3 months –0.015 0.051
6 months –0.024 –0.0002
9 months –0.020 0.076
STI at baseline
(clinic notes)
–0.047 –0.049 –0.077 –0.026 –0.083*
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Sexual health-care resource use and costs: from questionnaires
Sexual health-related resource use and costs are reported in Tables 14 and 15, respectively. There was no
significant difference in resource use between the two groups and there were only minor differences in
costs between the two groups. At p < 0.05, the intervention group had significantly higher costs of
self-tests for STIs: £1.85 (95% CI £0.00 to £7.45) versus £0.00. The control group had significantly higher
sexual health clinic costs at the 6-month follow-up: £48 (95% CI £0.00 to £143) versus £12.70 (95% CI
£0.00 to £54.70).
There was no significant difference in costs between the two groups with a total mean incremental cost of
–£24 (95% CI –£145 to £97) for the intervention minus the control group if pregnancy costs are excluded,
and –£65 (95% CI –£193 to £63) if the cost of pregnancy is included. Sexual health clinic costs accounted
for 88% of the cost in the control group and 84% of the cost in the intervention group.
Sexual health-care resource use and costs: from clinical files
Clinical files could be located for the sexual health clinic appointment directly after recruitment for 69
(92%) participants in the control group and 80 (95%) of participants in the intervention group. Thirty-five
participants (47%) in the control group had clinical records for appointments up to 12 months after
recruitment and 39 (46%) in the intervention group. Participants who attended the same sexual health
clinic after recruitment and whose clinical files could be located had an average of 2.3 appointments over
the 12 months for the control group and 2.5 appointments in the intervention group. This is compared
with the questionnaire data for which 40% of participants report a blood, swab or urine test at a sexual
health clinic in the control group at 12 months and 55% in the intervention group, with an average
number of attendances of two in the control group and 1.3 in the intervention group. The proportion with
appointments combined with the number of appointments results in a significantly higher average number
of appointments recorded in clinical files than in questionnaires for the intervention group (p = 0.04) but
does not differ significantly for the control group (p = 0.45).
TABLE 14 Number of participants and percentage that used each type of resource and average number of times
Resourcea













Condom pick-up 9 (27), 1.3 7 (20), 1 4 (9), 1 7 (13), 1.3 2 (9), 1 6 (8), 1
Self-test kit for STIs 0 1 (3), 1 0 2 (9), 1 1 (4), 1 3 (8), 1
GP resource use
Urine test/swab 6 (18), 1.2 0 2 (5), 1 3 (13), 1 1 (4), 1 1 (3), 1
Blood test 2 (6), 1 2 (6), 1 2 (6), 1 4 (17), 1 2 (9), 1 1 (3), 1
Treatment 1 (3), 1 1 (3), 1 0 2 (9), 1 0 0
Sexual Health Advice 2 (6), 1 4 (12), 1 0 2 (9), 1 0 0
Sexual Health Services
Urine test/swab 13 (38), 1.4 8 (23), 1.1 5 (12), 1.2 12 (52), 1.2 2 (9), 1 3 (8), 1
Blood test 10 (29), 1.5 6 (17), 1.2 5 (12), 1.2 11 (48), 1.2 2 (9), 1 4 (11), 1
Treatment 8 (24), 2 4 (11), 1 1 (2), 1 6 (26), 1 0 0
Sexual health advice 9 (26), 1.6 4 (11), 1.3 1 (2), 1 9 (39), 1.3 2 (9), 1 2 (6), 1
Sexual health counselling 0 0 0 1 (4), 1 0 0
Pregnancy (miscarriage) 1 (3), 1 0 1 (2), 1 0 0 0
a Calculated only for those using the resource.
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TABLE 15 Sexual health resource use: average cost (£) per participant (complete case analysis)
Resource

















Condom pick-up 0.71 (1.38) 0.4 (0.81) 0.19 (0.59) 1.18 (1.78) 0.35 (0.98) 0.17 (0.58) 0.11 (0.46) 0.60 (1.14)
Self-test kit for STIs 0 0.53 (3.12) 0* 0* 1.61 (5.32) 0.80 (3.86) 1.54 (5.19)* 1.85 (5.6)*
GP resource use (including tests and treatment) 15.91 (37.58) 6.83 (19.17) 3.12 (14.27) 24.33 (49.43) 19.65 (39.21) 5.13 (17.17) 1.89 (11.17) 25.9 (46.10)
Sexual Health Services (including tests and
treatment)
147 (241) 48 (95)* 20.63 (55) 188 (240) 121 (106) 12.70 (42)* 17.58 (43) 159 (131)
Sexual health counselling sessions 0 0 0 0 2.04 (9.8) 0 0 2.35 (10.5)
Pregnancy (miscarriage) 7.35 (64) 0 7.35(64) 14.69 (89) 0 0 0 0
Total cost (excluding pregnancy) 164 (257) 56 (110) 24 (62) 214 (264) 145 (129) 19 (53) 21 (49) 189 (159)

























































































































































































































































































































































































































































































Costs using a bottom-up costing approach and number of appointments attended pre-recruitment, directly
after recruitment and post recruitment using data only from participant clinical files are reported in Table 16.
If no record is available, it is assumed that there was no appointment and, hence, the cost was zero. There
was no significant difference in costs between the intervention and the control group. Adjusting for baseline
differences the incremental mean cost per participant of the intervention group compared with the control
group was £12 (95% CI –£8 to £32).
Quality-adjusted life-years decrement from sexually transmitted infections
and resource use from clinical records
Out of the 42 participants with complete QALY data and data available from clinical records, 10 participants
had a STI diagnosis at recruitment: genital warts, n = 6; genital chlamydia, n = 2; genital herpes, n = 1;
and urethritis, n = 1. Patients with a STI diagnosis at baseline had significantly lower QALYs of 0.843 over
the 12 months than 0.926 for participants with no diagnosis of STIs at baseline (p = 0.03).
To calculate QALYs for patients using the clinical files, a QALY decrement of 0.083 was applied to any
patient with a STI at baseline or who had a new STI diagnosis during the 12 months after recruitment.
All other patients had QALYs of 0.926 during the 12 months of the study.
There was no significant difference in QALYs between the control and the intervention group, with a
mean difference in QALYs for the intervention minus control of 0.004 (95% CI –0.011 to 0.020).
TABLE 16 Cost of sexual health clinical attendance per recruitment, following recruitment and post recruitment
Analysis
























1.79 (1.45) 1 2.26 (2.9) 1.57 (0.90) 1 2.54 (1.69)
Average (SD) cost (£) of
clinicians (participants
with records)
34 (37) 20 (4.5) 45 (58) 31 (29) 21 (8.8) 49 (34)
Average (SD) cost (£) of
tests (participants with
records)
57 (51) 37 (23) 41 (52) 41 (24) 34 (24) 47 (49)
Average (SD) cost (£) of
medications (participants
with records)
8.21 (24) 4.40 (15.1) 4.40 (15) 6.18 (12) 4.57 (14.93) 4.57 (15)
Average (SD) total cost
(£) (participants with
records)
115 (92) 63 (26) 95 81 (32) 60 (28) 107 (74)
Average (SD) total cost
(£) (all participants)
38 (76) 57 (31) 44 (86) 28 (43) 56 (31) 50 (74)
SD, standard deviation.
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Incremental cost-effectiveness ratios and cost-effectiveness
acceptability curves
In analyses 1, 2 and 4, the intervention dominates the control in that it results in more QALYs and lower
costs. In analyses 3 and 5, in which patient files are used to calculate costs, the intervention results in an
additional adjusted cost of £12 and is more effective (but not by a significant margin).
In analysis 3, in which QALYs are calculated based on the disutility of having a STI, the intervention results
in an additional 0.004 QALYs per participant for an additional cost of £12. This translates to a mean
incremental cost per QALY gained of £3000.
In analysis 5, in which costs are calculated from patient files, the intervention prevents four infections per
100 patient-years for an additional cost of £12 per patient. This translates to a mean incremental cost per
STI prevented of £291.
The CEACs are depicted in Figures 8 [for results calculated using the EQ-5D-3L (analysis 1) and those
derived from patient files (analysis 3)] and 9 [for results calculated using the SQoL questionnaire (analysis 2)].
Using data from questionnaire responses and calculating QALYs from the EQ-5D-3L, in 88% of instances
the intervention is cost-effective compared with control at the WTP for a QALY threshold of £20,000.
This is the same regardless of whether the cost of pregnancies is excluded or included. Using patient files
for resource use and calculating QALYs from the disutility of STIs, there is a 68% probability that the
intervention is cost-effective compared with control. If QALYs are calculated using the SQoL questionnaire,
there is a 61% probability the intervention is cost-effective if pregnancy costs are excluded and 69% if they
are included.
Cost of the website
The total cost of the developing the website was £101,515 (Table 17). Activities and costs not associated
with the intervention aspect of the website have already been excluded from the costs. In the trial,
84 participants in the intervention group accessed the website, resulting in a cost per patient of £1209
for the website.
Using the results of analysis 1, QALYs calculated from the EQ-5D-3L tariff and using responses to patient
questionnaires to calculate costs, the intervention resulted in an average cost saving of £24 per participant
in sexual health service use. Taking away the cost savings from the cost of the website leaves a total mean
cost per participant for the intervention group compared with the control group of £1185. There was an
adjusted QALY gain of 0.03 in the intervention group compared with the control group. This equates to an
incremental mean cost per QALY of £39,466.
There is no reason why access to the website should be limited to the 84 participants who accessed it as
part of the trial. Assuming that there is an average cost saving per participant accessing the intervention of
£24 and an average QALY gain per participant or 0.003, given there is no additional cost per participant to
access the website as the costs have already occurred, an additional 26 participants would need to access
the website for an ICER of £30,000, which is the upper end of the NICE threshold for cost-effectiveness.
Using the results from the clinical files, that is assuming that the intervention costs an average adjusted
cost of £12 more than no intervention and results in 0.004 QALYs, the current ICER is £305,128 per QALY
gained. An additional 856 participants would need to access the website for the ICER to be below
£30,000 with a cost per participant for the website of £108.
Discussion
This is the first cost–utility (cost per QALY gained) analysis of a digital intervention for sexual health that
we are aware of. As a result, the focus of this work has been to evaluate the different methods of
cost–utility and cost-effectiveness analysis and their impact on the results. Across the different analyses
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conducted, there is a 61–88% probability that the website is cost-effective compared with current practice
at a cost-effectiveness threshold of £20,000 per QALY gained. The impact of the cost of the website on
these results varies depending on assumptions made about how many people will access the intervention
in the future. It should be noted that this was an analysis of a feasibility trial with the aim of informing
methods for a Phase III trial. The design of any future trials should take into account the impact that
different methods of data collection (patient-completed data collection vs. data collection from clinical files)
have on the results of the cost-effectiveness analysis. If patient files are used, methods for capturing impact
on quality of life and the cost of unintended pregnancies will need to be considered.
As discussed, there were challenges following up participants to obtain responses to online questionnaires.
Follow-up using clinical files was feasible but did not yield significantly different results to questionnaire
data in the control group, and captured more appointments and costs in the intervention group than
would be expected based on completed trial outcome questionnaires. There was some concern that
clinical files would be less sensitive given that patients can choose any clinic to go to and, therefore, not all
clinic attendances may be captured. Although clinical files may miss some of the attendances, they
captured more costs than questionnaires and, hence, appear to be more valid.
In the clinical files analysis, an average QALY decrement was applied to a STI diagnosis in patient files
based on calculations using complete trial data. Although this provides a methodology for calculating
QALYs from clinical files that does not require patient follow-up, further work is required to obtain better
estimates of QALY decrements associated with STIs. This could be done by administering the EQ-5D-3L to
a large number of STI clinic attendees and collecting detailed data on their current and past sexual health
status. Alternatively, a new method for assessing the value people place on sexual health may need to
be developed. The utility decrement for STIs calculated using QALYs and the EQ-5D-3L utility score is
statistically significant at p < 0.05. Given the number of analyses run, this result could have occurred by
chance and should be interpreted with caution. The small sample size of 46 participants meant that
STI-specific decrements could not be calculated.
The majority of STIs were genital warts which, owing to their visible and symptomatic nature, are likely
to have a greater QALY decrement than STIs that can be present with no symptoms, such as chlamydia
and gonorrhoea. It is possible that a diagnosis of chlamydia or gonorrhoea may have an impact on quality
of life through having a negative impact on relationships or through anxiety over long-term health
implications. Further investigation is required as to what the EQ-5D-3L is measuring and if it is the most
appropriate outcome to use in sexual health promotion interventions, digital or otherwise.
TABLE 17 Cost components of the development of the intervention website
Cost component Activity Cost (£)
Preliminary intervention design £15 incentive for interviews with 27 participants 405
Focus groups for intervention development £20 incentive for 16 participants 320
Coding and development of website
Draft plan for website 5625
Outline of intervention 8438
Final draft of website 25,313
Testing and completion 16,875
Total website cost (intervention only) 56,250
Research associate full time for 1 year 75% of their time working on the intervention 34,543
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An additional concern with using clinical files from STI clinics is that they do not capture the cost of other
STI-related services. Questionnaire responses collected as part of the trial would suggest that, for this
patient group, most patients access STI services through sexual health clinics rather than their GP or
community-based services. Resource use for sexual health clinics accounted for 84–87% of costs, capturing
the majority of cost data.
Costs differed for cost per sexual health clinic appointment using the NHS payment tariff104 compared with
bottom-up costing. The bottom-up costing may, in some ways, be imprecise as there were data available
on which type of clinician the patient saw but not on duration of the contact. It was assumed that the
average appointment duration was 20 minutes, unless a diagnostic test was being conducted in which
case the appointment length was increased to 30 minutes. There is also limited information available on
the costs of diagnostic tests. STI clinics are likely to have bulk contracts with the laboratories that process
the diagnostic tests and, hence, are unlikely to know the cost per test. Even assuming appointments are
longer, the £63 calculated as the average cost per appointment using bottom-up costing is significantly
lower than the £105 value for the NHS tariff.
Website running costs were not included in the analyses, as there was no information available on
ongoing running costs. There were no requests from participants for technical assistance in using the
Men’s Safer Sex intervention website and any maintenance to the website during the trial was research-
related only. Based on the QALY gain of 0.003 per participant, an average cost saving of £24 and a WTP
for a QALY of £20,000, the website would need to cost £94 per person to be above the threshold for
cost-effectiveness. A larger, longer-running trial may provide additional information on what the ongoing
maintenance costs for a website of this sort may include.
Further work including decision-modelling may provide additional preliminary evidence of the potential
cost-effectiveness of the website intervention by incorporating additional evidence from the literature into
the model and extrapolating the findings over a longer time horizon. It may also yield information on
where further research is important if evidence is lacking and has implications for the cost or effectiveness
of the intervention.
Recommendations
l A future RCT should collect health economic data from clinic patient files rather than self-completed
questionnaires. Consideration still needs to be given as to if, and how, QALYs will be calculated and
how to collect costs on unintended pregnancies.
l Further research on the suitability of the EQ-5D-3L to calculate QALYs in sexual health-related
interventions.
l Further research is needed on the cost of STI clinic visits including staff salaries, time dedicated by each
staff member to a patient (including administrative time) and the cost of diagnostic tests.
l Development of a method to allocate per patient costs for digital interventions with unpredictable or
variable running costs.
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Chapter 5 Clinic staff and user views of the
Men’s Safer Sex website and online randomised
controlled trial
This chapter reports on a qualitative evaluation of the RCT research procedures, exploring the views ofclinic staff and male clinic users regarding online trial procedures and the potential of a sexual health
website for men in a sexual health clinic setting.
Aims
The main aim of this qualitative evaluation was to provide patient and clinic staff perspectives on online
trial procedures, to inform the optimum design of a future full-scale RCT.
Methods
Qualitative study design
The study was a qualitative interview study, using semistructured interviews. We used three qualitative
data sources to assess the acceptability and validity of the pilot RCT methodology: (1) individual interviews
with 11 male RCT participants, (2) individual interviews with nine clinic staff who assisted with the study
recruitment in each of the sexual health clinic research sites and (3) comments made in free-text boxes on
the 3-, 6- and 12-month online outcome questionnaires.
Data source 1: male sexual health clinic user interviews
Male study participants were recruited in the same way as participants in the Men’s Safer Sex pilot RCT,
registering on a tablet computer (iPad) placed in the waiting rooms of sexual health clinics. Forty-eight men
were invited to participate in interviews. Their experience of the RCT study procedures were the same,
except that e-mail follow-up was at 2 weeks only instead of at 3, 6, 9 and 12 months (to enhance recall of
trial procedures). An additional question in the online recruitment process asked permission to contact the
men for a post-study interview. Their quantitative outcome data were not included in the pilot RCT data
analysis. Ethics committee permission was provided by the City and East NHS Research Ethics Committee
(study reference number 13/LO/1801).
We interviewed 11 male sexual health clinic users who had enrolled for the Men’s Safer Sex pilot trial. In
order to recruit a diverse sample, as the recruitment proceeded we undertook theoretical sampling on the
basis of age, trial allocation condition (i.e. intervention or control) and response to follow-up (positive/
negative responses to requests for follow-up data).
Interview procedures
Participants were interviewed face to face or by telephone. The topic guide included questions regarding
methods of recruitment, online registration and consent, the receipt of incentives, online questionnaires,
contact/follow-up via e-mail and men’s views of the Men’s Safer Sex intervention website (i.e. preference
for access point, relevance and usefulness of website, etc.) (see Appendix 10). All participants were offered
£20 as a thank you for their participation. The interviews were conducted in a variety of settings including
sexual health centre side rooms, university offices or via skype™ (Microsoft Corporation, Redmond, WA,
USA) video link, and all participants were interviewed alone.
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Data source 2: staff interviews
Participant recruitment: clinic staff
We interviewed nine members of staff from the three clinic research sites. All staff members involved in
the recruitment to the trial were eligible to participate and we interviewed all staff who were directly
involved in the conduct of the trial. Staff were at different grades, with different levels of involvement in
the research (e.g. clinical staff who identified patients, research nurses who assisted in recruitment and
consent and receptionists who gave out leaflets to potential participants).
Interview procedures
All staff were interviewed face to face by a researcher from UCL who had not been involved in the trial in
any way. The topic guide included questions regarding their views on recruitment procedures and the
feasibility and usefulness of providing access to an IDI in a sexual health setting. The interviews were all
conducted in sexual health centres in clinic rooms and all participants were interviewed alone.
Analysis of qualitative interview data
ATLAS.ti software (version 7.5.11, Cincom Systems Inc., Berlin, Germany) was used to facilitate data
retrieval, coding and linkage, and to record analytic notes. Thematic analysis was used to identify patterns
and themes within the data. One researcher independently coded text from the transcripts, categorised
data by theme and identified relationships between different elements of the text. A data meeting was
held to discuss the coding schema and coding decisions were reviewed by a second researcher.
Data source 3: free-text questionnaire comments
Space was offered for voluntary free-text comments after each cluster of questions on the quantitative
online outcome questionnaires. At the end of each follow-up survey, participants were also asked whether
or not being in the study had any good or bad effects on their lives.
Quantitative survey data were available for 159 men after excluding men who withdrew from the study
and those later found to be ineligible. A total of 281 free-text comments on outcome questionnaires for
these 159 men were analysed. Forty-six men out of the 159 eligible participants commented on the good
or bad effects of the study at the end of at least one of the 3-, 6- or 12-month outcome questionnaires.
Comments were exported in a Microsoft Excel file and coded thematically in situ.
Results
Reasons for participating in the research
Participants commonly cited boredom and a desire to help the researchers as their main reasons for
participating. The promise of a voucher was described by many as an added bonus but most participants
said they would have taken part without this incentive. Features of the study which made it more
appealing were anonymity, the flexibility to fit around patients’ consultations and that it was short.
For most men, the particulars of the study were unimportant, but many were reassured by the academic
nature of the study and would have been less keen to participate had it been a marketing questionnaire
for a private company.
Participants’ understanding of the purpose of the research
Participants’ understanding of the research was often incomplete. Many felt it was purely an exercise in
data collection and did not realise that the website was intended as an intervention to change behaviours.
However, participants were happy to proceed without full understanding of the purpose of the research.
By virtue of the study’s affiliation with a university (UCL) and with the NHS, men trusted that the study
would be trying to do something good and that the details were not particularly important. Two
participants had initial concerns that the study may have been sponsored by condom manufacturers,
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which led them to feel cynical. Others agreed that they would have felt uncomfortable about participating
in a marketing questionnaire.
Experience of completing the research in the clinic
All three of the clinics offer sexual health appointments on a drop-in basis and the waiting time varies by
time of day and day of the week. The iPads were positioned so that men could access them while waiting
to see clinical staff but the placement of the iPads varied. In one clinic, the research was conducted in the
waiting room and in two clinics, participants were taken to a side room to complete research procedures
and see the Men’s Safer Sex website in private. Staff described the tensions between making the iPad
accessible in the main waiting room (and, thus, increasing access) and offering participants privacy. Some
felt uncomfortable approaching potential participants and explaining the study in a public waiting room,
especially as the study focused on MSW and staff sometimes knew that men were MSM who would not
be eligible. Male participants agreed that privacy was important and most felt happy with the location of
the iPad that they had experienced.
The staff who were interviewed had been concerned that patients might be worried about missing their
appointments and one of their important roles was to ensure that this did not happen. Participants’
worries about missing appointments were pre-empted by the staff who explained the study.
Attitudes towards online consent
Staff expressed mixed opinions of the self-directed online consent. Although it lessened paperwork and,
in theory, should have saved staff time and effort, many felt duty-bound to obtain verbal consent as well,
worried that participants may skim read or fail to understand. Participant interviews confirmed some of
these fears, with several male interviewees admitting to scanning the consent pages and many others
unable recall specific details (although this may also reflect difficulties recalling details ≥ 2 weeks
after enrolment):
Interviewer: . . . any other problems at all with the consent process?
Staff member 09, clinic 1: . . . it seemed like, I don’t know whether quite a long information sheet
on there . . . and, I think, a lot of people were sort of . . . you felt like they were whizzing through it;
and you’re thinking, you can’t possibly be reading this . . . and, obviously you’ve got to have all the
information in there . . . and I don’t know how you get around that; but some people seemed a bit,
you know, huffing and puffing because they were reading through it all, and then they’d scroll up and
they’d realise there’s another [unclear]. And I could see people being, oh, for God’s sake, but I didn’t
stop them obviously, they’ve got to read it. So I don’t know how you get around that because you’ve
got to have all the information in there. You have to have graphics don’t you, but I’m sure there must
be a way that you can bullet point it. I wonder if bullet points would be better?
The study materials featured UCL and NHS logos and participants trusted that researchers would protect
their anonymity and safety and were not interested in knowing the details of this.
Problems with software and Wi-Fi access
As discussed in Chapter 3, patient Wi-Fi access was problematic in all three clinics and there were multiple
problems with the research software. These problems were frustrating for potential research participants
and had an impact on recruitment and retention:
The Wi-Fi, we had a nightmare with that, and that genuinely like was a problem because, you know,
you’d get people in, they’d sit down and they wouldn’t be able to do it, and it was just so infuriating
because they could have been eligible, they could have been, you know, and I had one guy who was
so desperate to do it but the Wi-Fi wasn’t working, and it’s just things like that.
Staff member 09, clinic 1
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I mean, the only bad thing about the trial was, the follow up questionnaire, when you had to click the
link, it didn’t work . . . from the website, so I had to e-mail in, saying I can’t get in . . . and it turned
out the problem was, that if you already logged in, instead of taking you to the questionnaire, it took
you to your account page . . . I was bothered enough to . . . having already done the first thing, I was
kind of like, well, if they’re not aware of the issue, then no-one’s going to complete it, and the whole
thing is going to be a waste of everyone’s time.
Participant 340 (interviewee)
Online outcome questionnaire
The questionnaire content was acceptable to interviewees and men said that they were honest in their
questionnaire responses. Some commented that it was easier to be honest online than in person.
Interviewer: it’s just good for us to know, but were you honest in the answers that you gave in
the questionnaire?
Participant 355: Yes . . . You know, I don’t see the point in saying, oh, I’m not talking about that,
because it, at the end of the day, it can potentially harm the research, because you’re not getting the
true picture, and it doesn’t . . . you know, it’s very unlikely that I’m ever, you know, going to
knowingly meet any of the actual research team, you know, so . . .
Some interviewees did not realise the distinction between the Men’s Safer Sex intervention website and
the outcome questionnaire (and so were not clear about whether they were in the intervention or
control group).
Engagement with the Men’s Safer Sex website
There were eight sections of research-related information and procedures to complete as well as
the baseline questionnaire before intervention group participants could access the Men’s Safer Sex website
(see Appendix 6), which was a barrier to engagement as it took some time to complete the
research procedures.
. . . it’s hard to get people to interact with it, I think, because of the . . . but that’s because of the way
the research is done. [. . . ] So for example when I was . . . so when the patients are doing this it can
often take quite a while to get through all the data that you require. So, things like demographic data,
and there’s stuff about, I don’t know, sexual preferences, sexual performance, all that kind of stuff, it
takes a while to get through. And then by the time they do actually get to the website they aren’t really
engaged to use it for that long. Like, a lot of patients would, kind of, just say, I don’t know. Can I go?
Staff member 01, clinic 1
Potential impact of the study on sexual well-being
Our quantitative results showed no significant differences in measured outcomes (although, as a feasibility
RCT, the sample size was intentionally small). It was difficult for interviewees to unpick the influence of
the research (outcome measurements with or without viewing the Men’s Safer Sex website) from the
influence of visiting the clinic and the subsequent invitation for interview. However, participating in the
study did seem to change some men’s attitudes and sexual health behaviours.
For some, the act of filling in survey questions prompted some changes:
. . . when I had to do the test and the questions are put in front of you then I started to realise how
much I wasn’t being honest in my head . . . that’s what made me realise I had to change my life.
That’s when the study helped me so much.
Participant 372 (interviewee)
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I think it has been a positive experience. I found being submitted the same questions over and over
and having to answer them, offered me the chance to ponder over this topic that often I might have
overlooked. It has made me feel more conscious about my sex life.
Participant 332, control group, final comment on 12-month questionnaire
Made me think about protection and prevention before embarking on new relationship.
Participant 181, control group, final comment on 12-month questionnaire
It’s been good because it’s a little reminder to be careful if I were to cheat and it reminds me of going
to get tested at the hospital and how much I hated it and it's much easier just to wear a condom.
Participant 215, control group, final comment on 12-month questionnaire
Good. I am more responsible in the fact I’m more open to talking about contraception and protection.
Participant 199, control group, final comment on 12-month questionnaire
Good effects. Nice to reflect on this aspect of life. I also spent the first £10 voucher on a new yoga
mat. Thanks for that!
Participant 254, control group, free text comment on 6-month questionnaire
The outcome questions had no reported impact on other men, but the voucher incentives were valued.
I am not learning anything new, so it is not having any effect on my life beyond taking up some time
and providing me with amazon vouchers . . .
Participant 167, control group, final comment on 3-month questionnaire
Among the intervention group participants, it is difficult to separate the potential impact of outcome
measurement from impacts of viewing the Men’s Safer Sex website. Some participants learned new
information as a consequence of participating in the study (presumably from the Men’s Safer Sex website,
which contained multimedia features addressing STI transmission):
It has helped me understand more about the way that STI can be transmitted.
Participant 207, intervention group, free-text comment on 3-month questionnaire
There were differing views of the website’s promotion of condom use:
It has been helpful to revise good practice for safer sex. The study has reminded me of risk but not
necessarily offered any new solution. I can't help but feel you are trying to promote condoms, an old
message. Everything on the website comes back to ‘use a condom’ People, including me take absurd
risks because sex with a condom is not the same thing as sex without. There are condoms that work a
little better. Your website hedges around actually recommending a brand or type on the grounds of
pleasure. That's what people want to know. Is there a condom that I can forget that I'm wearing?
Participant 208, intervention group, final comment on 12-month questionnaire
. . . in a good way I feel that this study has really challenged my sexual habits and made me question
why I put my health at risk for a few seconds of intense pleasure when using condoms is not a chore
and could save my life.
Participant 218, intervention group, final comment on 3-month questionnaire
However, some men felt that condom use/safer sex was not relevant to them:
I appreciate the study and fully support it, but as I am in a long-term relationship with a single partner,
I find that a large amount of questions do not apply to me.
Participant 137, intervention group, comment on 6-month questionnaire
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Some felt that participating in the study had no effect on their sexual health.
Final comment box: has being a part of this study had any good or bad effects on your life?
[N]ot really to be honest. I feel that generally speaking it was very obvious the advice that was given,
although I do think it is very important to make people aware of some things that perhaps some
people do not see as being obvious. Personally I found it obvious and I do not feel that it has had any
affect on my sexual practice or my well being. However i am grateful to have taken part and I wish
you all the success with your study:)
Participant 304, intervention group, comment on 12-month questionnaire
Potential adverse impacts of the study
Although most comments on the effect of participating in the study were neutral or positive, one man
described an adverse impact of participating:
Final comment box: has being a part of this study had any good or bad effects on your life?
Not really, i mean, it reminds me of the sadness of losing my long term girlfriend and also imagining
her having sex with other people, which is quite painful to think about but, in terms of my own sexual
psychology i think i am fine . . . Honest answer . . . you did ask! ;)
Participant 304, intervention group, final comment on 3-month questionnaire
The place of digital interventions in sexual health care
Male clinic users and clinic staff were positive about the role that digital interventions could play in terms
of being a useful resource for sexual health information either before or after clinic appointments. Offering
a web-based resource in sexual health waiting rooms was felt to be appropriate.
I think the ideal time to do it would be the waiting room beforehand because you’ve almost got a
captive audience. You’ve got like, a marketeer’s dream, haven’t you, because you’ve got people who
can’t go anywhere, who are already actually by virtue of being there, a little bit engaged with the
subject you want to talk to them about. So, it’s a little bit easier to talk to them about sexual health
than just wondering up to them at Liverpool Street station and saying, I’m going to talk to you about
sexual health.
Participant 353 (interviewee)
Clinic staff felt that the website could have a useful role in providing access to additional information for
patients, at their convenience, but felt that a digital intervention could not and should not replace their
role in communicating directly with clinic users.
I think anybody who comes to the clinic has . . . we should be promoting it. It’s not there to substitute
any health education that we provide, it’s not there to substitute CBT [cognitive–behavioural therapy]
that the psychologist might want to give to the patient, or motivational interviewing that the health
advisor might want to do. It’s there as an additional tool to . . . that is accessible 24 hours a day to the
patient. And there’s nothing wrong with us making an advert of it in the clinic or having a computer
where patients can go and interact with in the waiting room, or having it as an app that they can
access on their phones from home. [. . .] I don’t think it changes . . . you are what you are. We cannot
be replaced by robots; this can only provide information but it almost ends up being almost one way
because it’s quite a rigid system. It can only give you information based on the questions that are
already set on the system. It doesn’t have the ability to pick up behaviour, it doesn’t have the ability to
pick up any verbal cues that young people might be asking or be uncomfortable with so it can’t
prompt, so it doesn’t replace human beings in any way, shape or form. [. . .] I think is has a role and
we can use it as a tool. I don’t think it should be there to replace what we do.
Staff member 08 (clinic 2)
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Clinic users agreed that face-to-face communication can offer advantages over digital interventions.
I don’t like the idea of it being used in a consultation because I, kind of, want to speak to the clinician
then who’s the expert. You know, sometimes clinicians ask a second question, which actually prompts
an outpouring of something that proves to be really useful and really, kind of, helps pinpoint a problem.
Participant 353 (interviewee)
Discussion
In summary, male clinic users felt that the Men’s Safer Sex website could be thought-provoking, especially for
men who do not want to discuss their sex lives. Both clinic staff and clinic users felt that web-based resources
could play a useful role in sexual health care, but were concerned that a website should supplement, but not
replace, face-to-face health care. The pilot RCT fitted well around clinical activities but men did not self-direct
to the iPads and technical problems hampered access and engagement with the website and data collection.
The location of the iPads – either in the waiting room or in a side room – meant a trade-off between
accessibility and privacy. Staff were more concerned about consent and confidentiality than clinic users.
The experiences of the sexual health questionnaire and follow-up procedures were widely positive and the
outcome questionnaire was sometimes thought-provoking and could constitute an intervention in itself.
Qualitative study limitations
We interviewed all staff who were directly involved in the conduct of the Men’s Safer Sex trial at the three
sexual health clinics. However, we interviewed only 11 male pilot trial participants (staff sickness meant
that it was not possible to conduct more participant interviews) and their views may not be representative
of other trial participants (particularly of men who dropped out of the trial). However, the qualitative
analysis gives useful insight into our research procedures and of the Men’s Safer Sex website and its
design, content and potential usefulness to male sexual health clinic users. Participants in the qualitative
study were interviewed 2 weeks after they had registered for the study to enhance recall. This means that
we do not have information about user views of follow-up procedures (e-mails, texts and telephone calls)
or men’s reactions to e-mail prompts to use the website after clinic visits.
Conclusions
The main message from our qualitative field work is that digital interventions can be a useful supplement
to NHS clinical care, but that technical problems must be ironed out before the benefits can be enjoyed.
Frameworks for assessing the ethical issues and potential risks of digital research (such as those developed
by the British Psychological Society81) would help researchers and ethical committee members to assess any
potential risks of online research, and robust protocols for data protection and secure data storage are
needed. Engagement with a health promotion website is a challenge in a setting in which digital health
care is not routinely provided and online research procedures need to be efficient, with minimal outcome
measurement to ensure that participants have time to engage with an intervention.
Public health policy advocates the use of digital interventions for health and these interventions have the
potential to offer cost-effective sexual health promotion; however, we encountered significant obstacles to
online research and to engagement with the Men’s Safer Sex website in NHS clinical settings. Off-the-shelf
software frameworks for online trials and universal access to Wi-Fi in clinics for patients are needed to
facilitate smooth conduct of online RCTs. Researcher effort was needed to guide men to the intervention
and in order to facilitate routine implementation, IDIs should be offered as components of standardised
pathways for sexual health care (e.g. offering online health promotion alongside clinic procedures such as
online appointment booking and/or sexual history data collection).
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Chapter 6 Next steps
The Men’s Safer Sex website was broadly well received by male patients and clinic staff and we wereable to measure the impact on the rate of STI acquisition by checking clinical notes. It is likely to be
feasible to conduct a future large-scale RCT to assess the impact of an online intervention using clinic STI
diagnoses as a primary outcome. However, technical errors and poor response limited collection of online
self-reported outcomes. There were challenges with unreliable software and lengthy research procedures
which hampered online self-reported data collection and access to the Men’s Safer Sex intervention.
Response rates were boosted by a larger level of incentive but remained poor (50%) at 12 months.
There were no reported harmful effects from the Men’s Safer Sex website and it has the potential to be
cost-effective. Qualitative evaluation indicates that the Men’s Safer Sex website can prompt useful changes
in attitudes and behaviour for some men. We need to know more about how the digital intervention might
work, for whom it might work, as well as when and how, to ensure that participants engage with a digital
intervention for long enough to effect change. Important challenges within the NHS are staff resistance
to digital interventions79 and patient access to IT (Wi-Fi) in clinic settings. These practical and technical
challenges need to be addressed before a large-scale RCT is warranted. There are still uncertainties related
to how best to evaluate the cost-effectiveness of websites that promote sexual health. This trial provided
evidence of the feasibility of collecting data from clinical files to calculate costs. Further work is required on
how to incorporate the costs of the website into the cost-effectiveness analysis, methods for calculating
QALYs or other measures of effectiveness in sexual health and obtaining more precise costs of a patient visit
to sexual health clinics.
The next steps are to:
l refine the Men’s Safer Sex website in the light of suggestions made by men and by clinic staff
l draw on our experiences and the latest software security protocols to develop a reliable, secure
software framework for online trials
l optimise online research procedures (e.g. information formats suitable for reading online, efficient
registration procedures, minimal baseline outcome measurement)
l conduct qualitative work with patients, clinic staff and other stakeholders to investigate the best ways
to incorporate digital health promotion into NHS clinic pathways, to benefit both patients and
clinic staff
l explore potential mechanisms of action of the Men’s Safer Sex digital interventions, including the best
ways to enhance engagement with the website, to make best use of opportunities for intervention
l develop more precise methods for estimation of the costs of service use and resources in sexual
health clinics
l conduct further research on outcome measures to use in evaluating the cost-effectiveness of Men’s
Safer Sex digital interventions
l conduct additional research and publish clearer guidance on how to incorporate the costs of website
development, maintenance and running costs into cost-effectiveness analyses.
Interactive digital interventions show exciting potential for health promotion;105 however, we first need to
know more about how to overcome barriers to digital intervention testing and implementation in NHS
clinical settings.
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Appendix 2 Information sheets for
interview study
University College London e-Health Unit, 
Research Department of Primary Care and 
Population Health, 
Royal Free Hospital, Upper Third Floor,  
Rowland Hill Street, 
London NW3 2PF 
 
 
Information Sheet for Participants in Research Studies 
                                                            
You will be given a copy of this information sheet. 
 
Title of Project: Men’s views on a computer-based intervention for sexual health  
 
This study has been approved by the NHS Research Ethics Committee (Project ID 
Number): 12/LO/1643 
Name Dr Julia Bailey 
Work Address e-Health Unit, 
Research Department of Primary Care and Population Health 
University College London, 
Upper third floor, Royal Free Hospital, 
Rowland Hill Street,  
London NW3 2PF 
Contact Details  [email]             Telephone: XXXXX 
We invite you to participate in this research project. You should only take part if you want to: 
choosing not to take part will not disadvantage you in any way. If you do decide to take part you are 
still free to withdraw at any time without giving a reason. Please read the following information and 
discuss with the researcher if you want to. Please ask if there is anything that is unclear, or if you 
need more information. 
    
Why are we doing this study? 
A research team at University College London are developing a website and mobile phone 
application for men who have attended a sexual health clinic.  
 
The new website and mobile phone app is likely to include advice about sexually transmitted 
infections, avoiding future infections, and advice on sexual problems. We would like to know 
whether a website or mobile phone app could be a good way for men to get advice and help for 
sexual health problems.  
 
Why have I been chosen? 
You have been invited to take part in this research because you are male, and have visited a sexual 
health clinic.  
 
What will happen to me if I take part? 
We would like to interview you to ask your views on: 
 
* Whether you think a sexual health website or mobile phone app could be useful  
* What kind of sexual health advice you might find helpful  
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* Your experiences and views on using condoms to prevent sexually transmitted infections 
* Your views on the design of a new website or mobile phone app (e.g. interactive features) 
* Your views on our future research plans (to test a new website or app)  
 
We would like to tape-record the interview with your permission. We will then summarise the things 
that different people say in interviews, and use the results to help design the new website and 
mobile phone app. 
 
Will I benefit from taking part? 
We hope that you will enjoy participating in this study and discussing sexual health issues. We hope 
that it will feel satisfying to have contributed to the design and content of a new website and mobile 
phone app which could help men in future. You will be offered £15 as a token of appreciation for 
your time 
 
Are there any risks involved? 
There is a risk that some subjects could be embarrassing or upsetting to discuss. We hope that it will 
still feel helpful to discuss these topics. You are free to stop an interview at any time. At the bottom 
of this information sheet there are the contact details for organisations which can help with a variety 
of issues. 
 
What if there is a problem?  
If you have a concern about any aspect of this study, please contact the principal investigator, Dr 
Julia Bailey [email]    Telephone: XXXX, or Dr Elizabeth Murray [email]   
 
What happens if something goes wrong? 
Every care will be taken in the course of this study. In the unlikely event that you are injured by 
taking part, compensation may be available. If you suspect that the injury is the result of negligence 
by the Sponsor (University College London) or the hospital then you may be able to claim 
compensation. After discussing with your research doctor, please make the claim in writing to Dr 
Julia Bailey who is the Chief Investigator for the research and is based at University College 
London. The Chief Investigator will then pass the claim to the Sponsor’s Insurers, via the Sponsor’s 
office. You may have to bear the costs of the legal action initially, and you should consult a lawyer 
about this. 
 
Regardless of this, if you wish to complain, or have any concerns about any aspect of the way you 
have been approached or treated by members of staff or about any side effects (adverse events) you 
may have experienced due to your participation in the research, the normal National Health Service 
complaints mechanisms are available to you. Please ask your research doctor if you would like 
more information on this. Details can be obtained from the Department of Health Website: 
http://www.dh.gov.uk  
 
What happens when the study stops? 
The computer-based intervention will be tested in another research study, to see whether it is useful 
to men who have had a sexually transmitted infection. 
 
Can I withdraw from the study once I’m in it? 
It is your decision whether to take part in the study or not. You are free to withdraw at any point 
without giving a reason. You may also choose to withdraw what you said after the group takes 
place. 
What will happen to the information I provide? 
Interviews will be tape-recorded and written down with your permission. The information you give 
and the results from the project will be kept confidential and anonymous. University College 
London finance department will need your name, address and signature to confirm that you received 
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the £15 payment. The researchers for this study and the finance department will be the only people 
who can access your information. All data will be collected and stored in accordance with the Data 
Protection Act 1998. Any quotations in publications or reports will be anonymous so that you 
cannot be identified. 
 
There are some legal limits to confidentiality which are important to know. We are obliged under 
the 'Working Together to Safeguard Children' legislation to consider informing social services or 
other agencies if we find out that the health, safety or welfare of a person under 18 is at grave risk. 
Similarly, if it becomes clear that you or someone else is at risk of domestic abuse or other harm, 
we will consider referring to a local Multi-Agency Risk Assessment Conference meeting, or the 
police. 
 
Who is organising and funding the study? 
The research is being run by Dr Julia Bailey from the University College London e-Health Unit, and 
is funded by the National Institute for Health Research Health Technology Assessment programme. 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research Ethics 
Committee, to protect your interests. This study has been approved by the East London and City 
Research Ethics Committee. 
 
Can I get general advice about taking part in research? 
Yes. INVOLVE is a national advisory group that supports greater public involvement in NHS, 
public health and social care research. You can find out more from www.invo.org.uk or telephone 
023 8065 1088 
Advice and help organisations 
 
Health services near you: NHS Choices 
http://www.nhs.uk/servicedirectories/Pages/ServiceSearch.aspx 
 
Advice about sexual health and HIV: Terrence Higgins Trust  
http://www.tht.org.uk 
 
Contraception and sexually transmitted infection: Family Planning Association 
http://www.fpa.org.uk/home 
 
Help after sexual assault: The Havens http://www.thehavens.org.uk 
 
Sort out stress http://www.sortoutstress.co.uk/site 
 
The Samaritans  http://www.samaritans.org 
 
Gay, bisexual and transgender health: PACE http://www.pacehealth.org.uk 
Julia Bailey 
 
University College London e-Health Unit 
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Appendix 3 Consent form for interviews
Informed Consent Form for Participants in Research Studies                                                              
Please complete this form after you have read the Information Sheet and/or listened to an explanation 
about the research.  
Title of Project: Men’s views on a computer-based intervention for sexual health  
This study has been approved by the NHS Research Ethics Committee (Project ID Number): 
12/LO/1643 
Thank you for your interest in taking part in this research. Before you agree to take part, the person 
organising the research must explain the project to you. 
If you have any questions arising from the Information Sheet or explanation already given to you, 
please ask the researcher before you to decide whether to join in. You will be given a copy of this 
Consent Form to keep.  
Participant’s Statement  
I (Name) ……………………………………………………………………….. 
Have read the notes written above and the Information Sheet, and understand what the study 
involves. 
Agree that the research project named above has been explained to me to my satisfaction. 
Understand that if I decide at any time that I no longer wish to take part in this project, I can 
notify the researchers involved and withdraw immediately.  
Consent to the processing of my personal information for the purposes of this research 
study. 
Understand that such information will be treated as strictly confidential and handled in 
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accordance with the provisions of the Data Protection Act 1998. 
Agree to the audio-recording of interviews or focus groups, and agree to the use of this 
material to fulfil the aims of the project. 
Agree that transcripts and audio-recordings may be used by others for future research once it 
has been made anonymous (e.g. using code numbers instead of names), providing ethical committee 
permission has been granted for any such future research.  
I agree to take part in this study 
 
 
Signature of participant:                    Date:  
 
Signature of researcher:                                                                                            Date:  
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Appendix 4 Topic guide for individual interviews
Men’s views on a computer-based intervention for sexual health 
What is this research for? 
We are developing a website and mobile phone application for men who have 
attended a sexual health clinic for treatment or advice on sexually transmitted 
infections.  
The new website and mobile phone app could include information such as 
advice about sexually transmitted infections, and advice on sexual problems.  
Aim of the interview:  
We would like your views on the design of the new website and mobile phone 
app - to help to decide which sexual health topics to include, and your views on 
programme designs. 
We would like your views on: 
 
* Whether you think a sexual health website or mobile phone app could be 
useful  
* What kind of sexual health advice you might find helpful  
* Your experiences and views on using condoms to prevent sexually 
transmitted infections 
* Your views on the design of a new website or mobile phone app  
Confidentiality:  
 
We will keep everything confidential unless you or someone else is in danger 
of harm 
We will use fake names in the report 
No information disclosed during the interview will be reported back to the 
clinic staff 
Interview: 1 hour. Free to stop at any time 
 
CONSENT FORM – Sign, and keep information sheet 
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Your opinions: design and content of a computer-based intervention for 
men 
 
Could you tell me a little bit about your internet usage? 
e.g., how much time you spend on the internet, and what devices you use to 
access it? 
 
Do you access the Internet for sexual health advice or information? 
What advice? Why via Internet or mobile phone? How helpful was the advice? 
 
Clinic visit, health promotion, condom use 
 
Why did you come to the clinic today? 
Did you receive a diagnosis or any treatment? 
How did you feel about this? 
Have you received any sexual health diagnosis in the past? 
 
If you have visited a sexual health clinic recently, what information or advice were 
you given? 
What do you think of the advice you were given? 
What information or advice would you have liked (but didn’t get) from the clinic? 
Were you encouraged to use condoms by clinic staff? 
By whom? What did they say? How did you feel about any advice you were given? 
I’d like to talk to you a bit about your personal use of condoms now. So I can put this 
in context, could you tell me a bit about what your situations is in terms of 
partners/relationships? 
What are your experiences and views on using condoms to prevent sexually 
transmitted infections? 
Do you use condoms? 
When? All the time? With who? 
How do you make the decision to use/not use condoms? 
If not, why not? 
Is there anything that you think might make you more inclined to use condoms more 
often? 
Do you use condoms for oral sex? 
Have you ever had any problems with condoms? 
Are you aware of different types of condoms? 
E.g., different sizes? 
 
Would you personally find a website useful after visiting a sexual health clinic? 
If yes, why? For which topics in particular? 
 
Would it interest you if the website contained information about: 
Sexual problems, e.g. (give list) 
Sexual pleasure, e.g., ‘sex tips’, ways to please a girl/woman, ways to make condoms 
sexy 
Might this make you more likely to look at the website? 
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 What do you think is the most important topic to include in a sexual health website? 
And the next? And the next? 
 
 
Here are some suggestions for topics which we might include in a new website and 
mobile phone app – which of these might you find useful?  
e.g. information on sexually transmitted infections, sexual problems, sexual pleasure 
– prioritise these with reasons 
 
 
Which interactive and multi-media features would interest you? (if any) 
(Give participant the list and give a brief outline of all components) 
For example: 











For which topics? Why? 
 
 
Do you think you might access the programme in the following ways?   
Touch-screen module on a laptop in clinic  
Website to be freely accessible at any time  
Mobile phone components (text-messages, and a smart phone ‘app’)  
Do you think an app would be useful in addition to or instead of a website? 
(Present pros and cons – accessible offline, stores information onto the phone, 
may not be accessible to all devices, would need to be downloaded and stored on 
desktop)  
 
Any other comments? 
 
Please fill in demographic questionnaire  
 
 
£15 and signature to confirm receipt of cash 
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Appendix 5 Advertisement poster/leaflet for
pilot trial




Never been diagnosed with HIV or Hepatitis? 
 
We would like to ask you to take part in an online study to test a new website which is 
designed to improve men’s sexual health 
Receive up to £50 in vouchers as a token of appreciation 
(£10 to £20 each time you complete a questionnaire) 
If you’d like to be involved, please go to the iPad in the waiting room.  
The computer will tell you what to do. 
 
You can also ask the research staff for more information (the reception staff will tell 
you where they are) 
 
Rosie Webster: [email]  
University College London e-Health Unit. Telephone: XXX 
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Appendix 6 Trial software framework
The trial software framework
THANK YOU Page 1: Home Page
Page 3: What’s involved? Study info
Page 2: Eligibility (male; aged 16 years 
and over; two or more partners and 





Page 4: Consent form
RANDOMISATION













Page 7: Sexual health 
questionnaire





• If website is inactive for 5 minutes
• If participant selects ‘Exit’ button/s
Page 8a:
 Interactive Intervention
and usual care – directed 
to intervention website
Page 8b:
Usual clinic care only – 






• Reminders about the study
• Intervention weblink
• Link to online survey at 
   3, 6 and 12 months
• Reminders about the study
• Link to online survey at 
   3, 6 and 12 months











DOI: 10.3310/hta20910 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 91
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Bailey et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
83
Wording of online registration software
Page 1: Homepage 
Interested in sexual health? Use the internet?  
We’re running a research study to test a sexual health website. 
We invite you to be involved. 
Why? 
 You could find out more about sex and sexual health 
 You will help in the testing of a website, which may help people like you to avoid sexually 
transmitted infections 






If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster on XXXX, email email@uucl.ac.uk ; or contact the local research staff on 
NNNNNNNNN. 
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Page 2: Eligibility 
Before we start, we need to check that you are suitable for the study.  
This information is completely anonymous (it won’t be linked your name), and will be kept 
confidential. 
 
1. What is your gender? (Male, female, transgender) (exclude all responses except Male  p2a) 
2. Please select your age (Under 16; 16 or over) (Exclude under 16s  p2a) 
3. How many sexual partners (male or female) have you had in the last year? (None, 1, 2, More 
than 2) (Exclude none or 1  p2a) 
4. In the last 3 months, did you use a condom every time you had penetrative sex (penis in 
vagina or anus)? (Yes, No, Don’t know, N/A) (Exclude Yes or N/A  p2a) 
5. Have you ever received a diagnosis of HIV or Hepatitis? (Yes/No/Don’t know) (Exclude Yes 
or Don’t know  p2a) 
6. Are you visiting the clinic today for these reasons? 
I have symptoms of a sexually transmitted infection (e.g. pain when peeing,  
discharge)       (Yes/No/Not sure)  
To get treatment for a sexually transmitted infection  (Yes/No/Not sure)   
To get treatment because a partner has a sexually transmitted infection  
(Yes/No/Not sure) 
(include if: (Q3 = 2 or more than 2 AND Q4 = No or Don’t know) OR ‘Yes’ to any Q6 item) 
7. Are your sexual partners generally male or female? 
A. Female only, never male 
B. More often female, and at least once male 
C. About equally often female and male 
D. More often male, and at least once female 
E.  Male only, never female 
F.  I have not had any sexual partners  
G. Other (please state) ………………………. 
(Exclude D, E, F, G) 
8. Do you have an active email account? (Yes, No) (Exclude No) 
9. Do you have access to the internet? (Yes, No) (Exclude No) 
 
If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster on XXXXX, email email@ucl.ac.uk ; or contact the local research staff on 
NNNNNNNNN. 
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Page 2a: Not eligible 
Thanks for your time. Unfortunately you are not suitable for the study.  
 
If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster XXXXX, email [email]  ; or contact the local research staff on NNNNNNNNN. 
Page 3: “Information about the research: The MenSS Study: a pilot trial to test an interactive 
sexual health website for men” (Include logos of all three NHS trusts, and UCL logo) 
 
Page 2b, Eligible 
Thank you, you are suitable to be in the study. 
 
Please read this information about the research study to decide whether you’d like to sign up.  
 
You should only take part if you want to. If you sign up, you will be free to stop at any time, 
and you do not have to give a reason.  
 
If you do take part, it will make no difference to the treatment you receive from the clinic. 
 
If you have any questions, please ask the research staff in the clinic (the receptionist will be 
able to tell you where to find them) or contact Rosie Webster on XXXX, email [email]  ; or contact the 
local research staff on NNNNN. 
 
The MenSS website has been designed for men in sexual health clinics (like this one). The 
website gives information about sexual health, sexual pleasure, and how to avoid sexually transmitted 
infections. It has been developed by men in sexual health clinics and a team of sexual health experts 
from University College London. The aim of this study is to test whether the website can help people 
like you to improve their sexual health. 
 
You have been invited because you are a man who is visiting a sexual health clinic. We want 
to know whether the MenSS sexual health website is helpful to men like you. We hope 166 men like 
you will sign up to the study. Half will be asked to review the website straight away and the other half 
will be asked to wait until the research is over (in a year's time). 
 
We hope that you will find the research interesting. 
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Page 3. What’s involved?  
This iPad will guide you through the steps.  
This is what will happen: 
1. You will be asked whether you agree to take part in the study 
 
2. You will then be asked to fill in a survey on this computer about yourself and your sexual 
life. It has questions like ‘How many times in the last 3 months have you had vaginal sex 
without a condom?’  You do not have to answer any questions that you don’t want to. This 
survey will take about 10 minutes. 
 
3. The computer will then put you in one of two groups: 
a. The ‘no website’ group. You will not be asked to do anything else today, but we will 
email you in 3, 6, 9, and 12 months to ask some more questions about your 
sexual health. These surveys will take between 5 and 15 minutes. If we don’t hear 
from you, we will remind you by email, text message and telephone. We will also 
send you text messages and emails from time to time to remind you about the study. 
You will be able to view the website at the end of the study (July 2015) 
b. The ‘website’ group. You will be asked to look at the website today (for about 10 
minutes), while you are waiting to see the doctor. After you have left the clinic, you 
can visit the website again at any time. We will send you text messages and emails to 
remind you about the website. We will also contact you in 3, 6, 9, and 12 months to 
ask you to answer some more questions about your sexual health. If we don’t 
hear from you, we will remind you by email, text message and telephone. 
Splitting people into two groups helps us to see whether there is any difference 
between people who look at the website and people who don’t look at the website. This tells 
us whether the website has been helpful.  
You have an equal chance of being put into each group. This will be decided by 
chance, by the computer, and cannot be changed.  
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4. After one year, we would like your permission to check your medical records at this clinic, to 
see how often you have visited, and whether you were diagnosed with any sexually 
transmitted infections  
 
5. We will send you a £10 online shopping voucher by email if you fill in online survey 
questions at 3 months, 6 months and 9 months, and another £20 online shopping voucher by 
email if you fill in the final online survey after one year. 
What will happen to my information? 
 All information you give will be confidential 
 All data will be stored in accordance with the Data Protection Act 1998 
 No information  will be given to the clinic staff. Only the research team will be able to see 
your information 
 Regulatory authorities in the NHS trust may wish to view research data, in order to check that 
we are doing everything correctly 
 The information that you give about sexual behaviour will not be linked to your name: we 
will use code numbers instead of names. 
 It will not be possible to identify individual participants in research reports 
 Other researchers may wish to use your anonymous questionnaire responses for future 
research if it has been approved by an ethics committee 
 We will only use your contact details to contact you about the research study – these will 
NOT be given to anyone else 
 
• This study has been approved by the London: City and East Research Ethics Committee (REC number 13 LO 
1801). 
• The research will be published in a report and the results will be available online. It will not be possible to 
identify any individuals in these reports. 
• You will receive a summary of the results by email at the end of the study. 
• All information that you provide will remain confidential and will be used only for the study.  
• However, if you give us specific information which leads us to think that you or someone else is at risk 
of harm, we are obliged to consider discussing this with authorities such as child protection teams, or 
the police 
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• You can withdraw from the study at any time, without giving a reason. To do this, please contact Rosie Webster 
XXXXX [email]. We may still use your anonymous questionnaire responses. 
o Once the findings of the study have been published in a research report, you will no longer be 
able to withdraw from the study. 
• The research team cannot offer individual sexual health advice 
• We hope that you find the research interesting, but you may find some of the questions or topics embarrassing 
or upsetting. We will provide contact details of organisations who may be able to help you 
• Please contact the researcher Rosie Webster if you have any questions or concerns about the research, on 
XXXXX [email]; Julia Bailey, [email] 
o You can also contact the principal investigator within your clinic: 
 Homerton Hospital: Professor Jane Anderson [email] 
 St Bartholomew’s Hospital : Dr. Claudia Estcourt [email] 
 Coventry sexual health clinic: Dr. Belinda Stanley [email]  
If you wish to complain, or have any concerns about any aspect of the way you have been approached 
or treated by members of staff you may have experienced due to your participation in the research, National 
Health Service or UCL complaints mechanisms are available to you. Please ask your research doctor if you 
would like more information on this. In the unlikely event that you are harmed by taking part in this study, 
compensation may be available. If you suspect that the harm is the result of the Sponsor’s (University College 
London) or the hospital's negligence then you may be able to claim compensation.  After discussing with your 
research doctor, please make the claim in writing to the Julia Bailey, [email] who is the Chief Investigator for 
the research and is based at University College London. The Chief Investigator will then pass the claim to the 
Sponsor’s Insurers, via the Sponsor’s office. You may have to bear the costs of the legal action initially, and you 
should consult a lawyer about this. 
• If you would like general advice about being involved in research, please see the INVOLVE website: 
www.invo.org.uk  
• You can get independent advice about your care or involvement in this research from the Patient Advisory and 
Liaison Service (PALS): 
o Homerton: 
Tel: 020 8510 7315  
Email: pals@homerton.nhs.uk 
o Barts: 
Tel: 020 3594 2040 
Email: pals@bartshealth.nhs.uk   
o Coventry: 
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Tel: 024 7653 6804 
Text message: 07826 900 926 
Email: pals@covwarkpt.nhs.uk  
 
If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster on XXXX email [email]; or contact the local research staff on NNNNNNN. 
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Page 4: Consent form  
(Include logos of all three NHS trusts, and UCL logo) 
Please read the following statements and tick the boxes if you agree with them. 
1. I have read the study information and understand what the study involves  
2. I understand that I can withdraw from the study at any time 
3. I agree for the research team to record all contact details, questionnaire responses, and 
information about my use of the MenSS website 
4. I understand that my information will be treated as confidential and handled in accordance 
with the Data Protection Act 1998 
5. I understand that relevant sections of my medical notes and data collected during the study,  
may be looked at by individuals from UCL, from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research. I give permission for these 
individuals to have access to my records. 
6. I agree that my anonymous questionnaire answers may be used by others for future research 
which has been approved by an ethics committee 
7. I agree for the research team to access my clinic records to get information about sexually 
transmitted infection diagnoses 
8. I agree to take part in this study 
 
(All Yes/No responses, if any ‘No’ responses direct to page 4b) 
 




Back (to p3) 






If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster on XXXXX, email V[email]  ; or contact the local research staff on NNNNNNN. 
 
          
Back 
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Page 4a:  
If you would like some more time to think about whether you want to 
sign up, please leave the tablet for the next person to use. You can come back to 
the tablet and sign up for the study at any time during your clinic visit. 
   
Page 4b: Not consented 
Thanks for your interest. Unfortunately if you do not agree to all the 
statements, you cannot be in the study.  
 
If you would like to reconsider, please press ‘back’. You may enter your 
responses again. 
 
Thank you for your time.     
                                                                               Back 
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Page 5: Registration details (contact details and password) 
 
We need your contact details for the following reasons: 
 To email and text you information about the study, reminders about the website, and links to 
questionnaires 
 To send you your £10 and £20 vouchers  
You contact details will remain completely confidential. We will not use them for anything 
other than the research study.  
Note: If you do not give your contact details, or give incorrect contact details, you will not be 





Mobile phone number: 
(We will now send you a verification code by text message. This it to confirm that you have 
typed your mobile number in correctly. Once you have received it, please enter it into the box below) 
Verification code: 
 
Please create a password. You will be asked for this every time you access the website, or 
complete a questionnaire. This is so that we know who has answered the questions or looked at the 






(Reject participants without an email address and mobile phone number– if not, direct to 
page 5a)  
 
 
If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster on XXXXX, email [email] ; or contact the local research staff on NNNNNNN. 
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Page 5a: Did not supply contacts or password 
You have not entered a valid email address, mobile number or password.  
Please press back to re-enter.       
                                        Back 
 
If you do not want to give this information, please click this button to exit 
the study registration. 
                                                                        Home 
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Page 6: Demographic questionnaire 
Thank you and welcome to the MenSS research study. 
The next step is to fill in an online survey. This will include some questions about you, and 
some questions about your sexual behaviour.  
 
The survey takes less than 10 minutes  
 
Please answer as honestly as you can. All answers are confidential. 
 
(Demographic questionnaire leading straight into sexual health questionnaire.) 
 
 





Page 8a: Intervention group – informed and directed to intervention 
 
Thank you for completing the survey. You have been put into the ‘website’ group. Please 
look at the MenSS website now, while you are waiting in the clinic. 
 
If you no longer want to look at it, or are called in by the doctor, please click one of the ‘quit’ 
buttons that are on each page: 
 
Want to quit the website 
 
Called in to doctor or nurse 
 
You will also have access to the website (link to MenSS website) over the next 12 months. 
We will email and text you the link to it, with a reminder about your password. 
 
 
Page 8b: Control group – informed and free to leave 
 
Thank you for completing the online survey. You have been put in the ‘no website’ group. 
You are not required to do anything else today. We will email you in 3, 6, 9, and 12 months to ask 
you about your sexual health, and then show you the MenSS website. 
 
Thank you for your time.  
 
 
Page 9: End of intervention viewing 
(Shown after hitting one of the quit buttons, or after completing all designated in-clinic 
activities)  
 
Thank you for looking at the website.  
 
You will now have access to the new website (URL) over the next 12 months. We will email 
and text you the link to this, so you do not have to remember it. 
 
If you have any questions, please ask the research staff in the clinic (the receptionist will be able to tell you where 
to find them) or contact Rosie Webster on XXXXX, email [email]; or contact the local research staff on NNNNNN.  
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Appendix 7 Questionnaire for pilot trial
Questions 
Your behaviour 
1. In the last 3 months how many of these types of female partners have you had sex with? 
Regular partner   …… 
Occasional partner, e.g. friends with benefits   …… 
One off partner (e.g. one night stand)  …… 
Sex worker (paid for)  …… 
Other  …….  
(please specify): ………………………………… 
(Text boxes restricted to 3 digit number for each option; free text box for ‘please specify’) 
2. In the last 3 months how many of these types of male partners have you had sex with? 
Regular partner   …… 
Occasional partner, e.g. friends with benefits   …… 
One off partner (e.g. one night stand)  …… 
Sex worker (paid for)  …… 
Other  …….  
(please specify): ………………………………… 
(Text boxes restricted to 3 digit number for each option; free text box for ‘please specify’) 
 Condom use 
3. In the last 3 months, how many women have you had condomless vaginal or anal sex with (without a 
condom)? 
(Free text response, restricted to 3 digits numeric) 
4. In the last 3 months, how many TIMES have you had condomless vaginal or anal sex with a woman 
(without a condom)? (Please answer as accurately as you can) 
(Free text response, restricted to 3 digits numeric) 
 
6. In the last 3 months, how many times have you experienced any of the following problems? 
Condoms not available when needed  0      1      2      3 or more 
Using condoms stored in wallet  more than 1 
month 
 0      1      2      3 or more 
Using condoms that were not lubricated   0      1      2      3 or more 
Applied condom after sex had begun  0      1      2      3 or more 
Removed condom before sex ended   0      1      2      3 or more 
Did not change condoms when switching 
from one form of sex to another 
 0      1      2      3 or more 
Erection lost when putting on a condom   0      1      2      3 or more 
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Erection lost during sex  0      1      2      3 or more 
Condom broke   0      1      2      3 or more 
Condom slipped off during sex  0      1      2      3 or more 
Condom slipped off during withdrawal   0      1      2      3 or more 
Ejaculate dripped onto partner’s genitals   0      1      2      3 or more 
Condom put on penis the wrong way, then 
turned and put on the right way 
 0      1      2      3 or more 
Did not change condoms when switching 
from one partner to another 
 0      1      2      3 or more 
7. In the last 3 months, how many times have you had condomless sex (without a condom) because you 
were drunk or high? (Please answer as accurately as you can) 
8. In the last 3 months, have you used these types of contraception with female partners ?  
Tick all that apply 
 Don’t know 
 None 
 None –trying for a baby 
 The Pill, contraceptive patch, or contraceptive vaginal ring  
 Condoms (including female condoms) 
 Emergency contraceptive pill (morning after pill) 
 Injection 
 Contraceptive implant 
 Withdrawal (pulling out) 
 Intrauterine device (coil/IUD/IUS) 
 Diaphragm or cap or spermicide 
 Natural family planning (safe period/rhythm method) 
 Don't know name of the contraception 
 Other (please state)………………………… 
STI diagnoses 
9. In the last 3 months, have you had any of the following sexually transmitted infections (tick all that 
apply)?  
  Warts  
  Herpes 
  Chlamydia  
  Gonorrhoea 
  Pubic lice (Crabs) 
  Trichomonas (TV) 
 Non-specific urethritis (NSU) 
  Syphilis 
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  HIV 
  Hepatitis 
  Can’t remember the name  
  Other (please write in name)  
………………………………………………… 
 No sexually transmitted infections 
10. In the last 3 months have you had antibiotic treatment because a partner had an STI? 
 Yes      
No       
1. Has a female partner been pregnant in the last 3 months? 
  Yes      
  No   
  Don’t know  
(If yes)  What happened with the pregnancy? 
 Still pregnant 
 Miscarriage or stillbirth 
 An abortion 
 A baby 
  Don’t know 
2. In the last 3 months, how many times have you used each of these sexual health services? 
Condom pick-up  …… 
Self-test kit for STIs* (e.g. postal Chlamydia test kit)  …… 
Urine tests/swabs at the GP …… 
Urine tests/swabs at a sexual health clinic …… 
Blood tests for STIs at the GP)  …… 
Blood tests for STIs at a sexual health clinic …… 
Treatment of an STI at the GP …… 
Treatment of an STI at a sexual health clinic 
Sexual health advice from the GP …… 
Sexual health advice from a sexual health clinic …….. 
Outreach contraception and sexual service (CASH) …….. 
Sexual health counselling or therapy …… 
Other sexual health services ……  
(please state) ……………………………… 
(Text boxes restricted to 3 digit number for each option; free text box for ‘please state’) 
*STIs = Sexually Transmitted Infections  
* GP = General practitioner, family doctor 
Self-efficacy  
3. I feel confident that I could:  
Get hold of condoms (eg buying from a shop) 
Use a condom on correctly 
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Put a condom on without losing my erection 
Remove and dispose of a condom after sex 
Choose the correct size/type of condom 
Discuss using condoms with any partner I might 
have 
Suggest using a condom with a new partner 
Suggest using a condom without my partner 
feeling ‘diseased’ 
Remember to use a condom even if I am drunk or 
high 
Stop to put a condom on myself or my partner 
even in the heat of the moment  
 
Knowledge 
4. True or false? 
Whether or not people get sexually transmitted 
infections (STIs) is just luck. 
 True    False    Unsure of answer 
You would know if you had an STI, without needing 
a test  
 True    False    Unsure of answer 
You can tell who is likely to have an STI   True    False    Unsure of answer 
You can have HIV and not know  True    False    Unsure of answer 
You can catch STIs from oral sex  True    False    Unsure of answer 
If you are in a relationship, you are safe from 
catching STIs  
 True    False    Unsure of answer 
You are less likely to catch an STI from someone 
you know  
 True    False    Unsure of answer 
Some STIs can’t be treated  True    False    Unsure of answer 
With a condom on, the man should wait until the 
penis is soft before withdrawing after sex 
 True    False    Unsure of answer 
Baby oil or Vaseline is a good lubricant to use on a 
condom 
 True    False    Unsure of answer 
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Standard sized condoms are suitable for all men  True    False    Unsure of answer 
 Levels:  
True = 1 
False = 0 
Unsure = 2 
Motivation 
5. Thinking about situations when you will have sex in the future, which of the following best applies to 
you? 
 I do not want to wear a condom 
 I am not sure if I will want to wear a condom  
 I might want to wear a condom  





8. Do you agree or disagree with the following statements? 
Condoms feel unnatural strongly disagree   disagree   undecided  agree   
 strongly agree 
Condoms interrupt the mood strongly disagree   disagree   undecided  agree   
 strongly agree 
Condoms don’t feel good strongly disagree   disagree   undecided  agree   
 strongly agree 
Condoms reduce the quality of the climax or orgasm strongly disagree   disagree   undecided  agree   
 strongly agree 
Condoms are uncomfortable strongly disagree   disagree   undecided  agree   
 strongly agree 
Condoms don’t fit right strongly disagree   disagree   undecided  agree   
 strongly agree 
I feel closer to my partner without a condom strongly disagree   disagree   undecided  agree   
 strongly agree 
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Using a condom helps me worry less during sex strongly disagree   disagree   undecided  agree   
 strongly agree 
Using a condom helps my partner/s worry less during 
sex 
strongly disagree   disagree   undecided  agree   
 strongly agree 
 Levels: 
strongly disagree = 1 
disagree = 2 
undecided = 3 
agree = 4 
strongly agree = 5 
Communication 
9. During the last 3 months, have you discussed the following things with partner(s)?  
How to prevent pregnancy  Yes      No       
How to use condoms  Yes      No       
How to prevent STIs and HIV  Yes      No       
Your sex history  Yes      No       
Their sex history  Yes      No       
  
Identity 
10. Do you agree or disagree with the following statements? 
I feel I am a responsible person, which is why I use 
condoms  
strongly disagree   disagree   undecided  agree   
 strongly agree 
I feel I am a spontaneous person, which is why I 
don’t use condoms  
strongly disagree   disagree   undecided  agree   
 strongly agree 
Using condoms is the woman’s responsibility  strongly disagree   disagree   undecided  agree   
 strongly agree 
Condoms make me feel less of a man strongly disagree   disagree   undecided  agree   
 strongly agree 
I use condoms because I am concerned about my 
health 
strongly disagree   disagree   undecided  agree   
 strongly agree 
I use condoms because I am concerned about my 
partners health  
strongly disagree   disagree   undecided  agree   
 strongly agree 
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Getting a girl pregnant proves that I am a real man strongly disagree   disagree   undecided  agree   
 strongly agree 














Under each heading, please tick the ONE box that best describes your health TODAY  
12. Mobility (walking about)  
  I have no problems walking about  
  I have some problems walking about  
  I have a lot of problems walking about  
13. Looking after myself  
  I have no problems washing or dressing myself  
  I have some problems washing or dressing myself  
  I have a lot of problems washing or dressing myself  
14. Doing usual activities (for example, going to school, hobbies, sports, playing, doing things with family 
or friends)  
  I have no problems doing my usual activities  
  I have some problems doing my usual activities  
  I have a lot of problems doing my usual activities  
15. Having pain or discomfort  
  I have no pain or discomfort  
  I have some pain or discomfort  
  I have a lot of pain or discomfort  
16. Feeling worried, sad or unhappy  
  I am not worried, sad or unhappy  
  I am a bit worried, sad or unhappy  
  I am very worried, sad or unhappy  
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17. We would like to know how good or bad your 
health is TODAY.  
This line is numbered from 0 to 100.  
100 means the best health you can imagine.  
0 means the worst health you can imagine.  
Please mark an X on the line that shows how good 
or bad your health is TODAY.  
How good is your health TODAY  
 










The worst health you can imagine 
18. Has being a part of this study had any good or bad effects on your life? Please explain how: 
 
 
(Free text box) 
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Appendix 8 Information sheet for qualitative
evaluation of trial procedures interviews: participants
Information Sheet for Participants in Research Studies 
                                                           
You will be given a copy of this information sheet. 
 
Title of Project: The MenSS Study: a pilot trial to test an interactive sexual health website for 
men  
This study has been approved by the NHS Research Ethics Committee: 13 LO 1801 
Name Dr Julia Bailey 
Work Address e-Health Unit, 
Research Department of Primary Care and Population Health 
University College London, 
Upper third floor, Royal Free Hospital, 
Rowland Hill Street,  
London NW3 2PF 
Contact Details  [email]             Telephone: XXXXX 
We invite you to participate in this research project. You should only take part if you want to: 
choosing not to take part will not disadvantage you in any way. If you do decide to take part you are 
still free to withdraw at any time without giving a reason. Please read the following information and 
discuss with the researcher if you want to. Please ask if there is anything that is unclear, or if you 
need more information. 
 
   Why are we doing this study? 
You recently took part in a study to test the MenSS website. We’d really like to interview you now 
to ask you what you thought of being in the research study, and to ask your opinion of the usefulness 
of websites for sexual health for men.  
 
We hope that you will find the research interesting. What you say might help us to work out the best 
ways to run research in sexual health clinics and online. 
 
What’s involved?  
This study involves an interview with a member of our research team. They will ask you questions 
about what you thought about being in the research study, and your opinions on the usefulness of 
sexual health websites for men. Do not worry if you have not seen the website, we will show it to 
you again. The interview will be in the clinic that you attended, or in central London. We can also do 
it over the phone or using Skype. The interview will take about an hour. We’ll pay you £20 for 
helping us out. 
 
The interview will include questions like: 
- Why did you sign up for the research trial? 
- Do you think that doing the survey made you think about your sexual health differently? 
- Do you think the website would be useful to you? 
 
What will happen to my information? 
 All information you give will be confidential 
 All data will be stored in accordance with the Data Protection Act 1998 
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 No information will be given to the clinic staff. Only the research team will be able to 
see your information 
 Regulatory authorities in the NHS trust may wish to view research data, in order to 
check that we are doing everything correctly 
 The information that you give will not be linked to your name: we will use code 
numbers instead of names. 
 It will not be possible to identify individual participants in research reports 
 Other researchers may wish to use your anonymous interview responses for future 
research if it has been approved by an ethics committee 
 We will only use your contact details to contact you about the research study – these 
will NOT be given to anyone else 
 
The small print. 
 This study has been approved by the London – City and East Research Ethics Committee 
(REC number 13 LO 1801). 
 The research will be published in a report and the results will be available online. It will not 
be possible to identify any individuals in these reports. 
 You will receive a summary of the results by email at the end of the study. 
 All information that you provide will remain confidential and will be used only for the study.  
 However, if you give us specific information which leads us to think that you or someone 
else is at risk of harm, we are obliged to consider discussing this with authorities such as 
child protection teams, or the police 
 You can withdraw from the study at any time, without giving a reason. To do this, please 
contact Rosie Webster XXXXX [email]. We may still use your anonymous questionnaire 
responses. 
 Once the findings of the study have been published in a research report, you will no longer be 
able to withdraw from the study. 
 The research team cannot offer individual sexual health advice 
 We hope that you find the research interesting, but you may find some of the questions or 
topics embarrassing or upsetting. We will provide contact details of organisations who may 
be able to help you 
 Please contact the researcher Rosie Webster if you have any questions or concerns about the 
research, XXXXX [email]; Julia Bailey, XXXXX [email]  
 
o You can also contact the principal investigator within your clinic: 
 Homerton Hospital: Professor Jane Anderson [email]  
 St Bartholomew’s Hospital : Dr. Claudia Estcourt [email]  
 Coventry sexual health clinic: Dr. Belinda Stanley [email]  
 
 If you wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated by members of staff you may have experienced due to your 
participation in the research, National Health Service or UCL complaints mechanisms are 
available to you. Please ask your research doctor if you would like more information on this. 
In the unlikely event that you are harmed by taking part in this study, compensation may be 
available. If you suspect that the harm is the result of the Sponsor’s (University College 
London) or the hospital's negligence then you may be able to claim compensation.  After 
discussing with your research doctor, please make the claim in writing to the Julia Bailey, 
[email] who is the Chief Investigator for the research and is based at University College 
APPENDIX 8
NIHR Journals Library www.journalslibrary.nihr.ac.uk
106
London. The Chief Investigator will then pass the claim to the Sponsor’s Insurers, via the 
Sponsor’s office. You may have to bear the costs of the legal action initially, and you should 
consult a lawyer about this. 
 If you would like general advice about being involved in research, please see the INVOLVE 
website: www.invo.org.uk  
 
 You can get independent advice about your care or involvement in this research from the 
Patient Advisory and Liaison Service (PALS): 
o Homerton: 
 Tel: 020 8510 7315  
 Email: pals@homerton.nhs.uk 
o Barts: 
 Tel: 020 3594 2040 
 Email: pals@bartshealth.nhs.uk   
o Coventry: 
 Tel: 024 7653 6804 
 Text message: 07826 900 926 
 Email: pals@covwarkpt.nhs.uk 
 
 This research has been approved by the London – City and East NHS Research Ethics 
Committee. 
Advice and help organisations 
Health services near you: NHS Choices 
http://www.nhs.uk/servicedirectories/Pages/ServiceSearch.aspx 
Advice about sexual health and HIV: Terrence Higgins Trust  
http://www.tht.org.uk 
Contraception and sexually transmitted infection: Family Planning Association 
http://www.fpa.org.uk/home 
Help after sexual assault: The Havens http://www.thehavens.org.uk 
Sort out stress http://www.sortoutstress.co.uk/site 
The Samaritans  http://www.samaritans.org 
Gay, bisexual and transgender health: PACE http://www.pacehealth.org.uk 
Julia Bailey 
University College London e-Health Unit 
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Appendix 9 Consent form for qualitative
evaluation interviews
Informed Consent Form for Participants in Research Studies 
                                                                        
Please complete this form after you have read the Information Sheet about the research.  
The MenSS Study: a pilot trial to test an interactive sexual health website for men  
This study has been approved by the NHS Research Ethics Committee: 13 LO 1801 
 
Thank you for your interest in taking part in this research. Before you agree to take part, the 
person organising the research must explain the project to you.If you have any questions, please 
ask the researcher before you to decide whether to join in.  
You will be given a copy of this Consent Form to keep and refer to at any time.  
 
(Please write your name) ………………………………………………………………………. 
 
(Please initial boxes) 
I have read Information Sheet and/or discussed the study with the researcher/s 
  
I understand what the study involves. 
  
I understand that if I change my mind and no longer want to take part in this project, I can tell the 
researchers and withdraw immediately.  
  
I agree that researchers can use and store my personal information (e.g. my name and contact 
details) for the purposes of this research study only  
  
I understand that such information will be treated as strictly confidential and handled in 
accordance with the provisions of the Data Protection Act 1998. 
  
I understand that my interview will be audio recorded and that what I say may be quoted 
anonymously  
  
I understand that relevant sections of my medical notes and data collected during the study,  
may be looked at by individuals from UCL, from regulatory authorities or from the NHS Trust, 
where it is relevant to my taking part in this research. I give permission for these  
individuals to have access to my records. 
  
I understand that the research findings will be posted online and published as reports or papers, but 
that it will not be possible to identify me in any publications. 
  
The research project named above has been explained to me to my satisfaction and I agree to take 
part in this study.  
  
I agree that my interview may be used by others for future research once it has been made 
anonymous (e.g. by using code numbers instead of names) 
  
Signature of participant:        Date:       
Signature of researcher:        Date:       
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Appendix 10 Topic guide for interviews with
trial participants
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Appendix 11 Statistical analysis plan
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